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Abstract 
 
Macrophages are found in almost every tissue, from embryonic to adulthood, with trophic 
roles during development. In organs such as brain, kidney, mammary gland and pancreas, 
macrophages reside in considerable number and provide important regulatory functions that 
shape their development and maturation. Some studies have demonstrated the regulation of 
developmental morphogenesis by macrophages, more specifically in vascular system formation 
and branching morphogenesis. Lung is a branching organ and its morphogenesis is dependent 
on interactions between epithelial and endothelial compartments. Indeed, in fetal lung, 
macrophages represent around 2-5% of the total lung cells. However, their precise contribution to 
lung development remains unknown. In this way, the main goal of this work was to unfold the 
functional role of tissue macrophages on lung development. Therefore, we aimed to understand 
whether and how macrophage ablation impaired fetal and neonatal lung development, using a 
macrophage-deficient mouse model (Csf1r-/- mice). The first aim was to characterize lung 
morphology of Csf1r-/- versus wild type and Csf1r+/- mice. We performed lung stereological analysis 
(calculation of mesenchymal, epithelial and air space volume density (VD)) at pseudoglandular 
(embryonic day (E) 15.5), fetal saccular (E18.5) and at post-natal saccular (after birth, P0) 
developmental stages. The lung mesenchymal VD in Csf1r+/- and Csf1r-/- mice was increased 
when compared with wild type mice in all stages analysed. At E18.5, beyond an increase in lung 
mesenchymal, a decrease of epithelial and airspace VD was observed in Csf1r-/- mice. Finally, at 
P0 stage, Csf1r-/- derived lungs showed a decrease in bronchiolar and air space VD as well as an 
increase in the mesenchymal VD compared with control group. These results suggested a delay 
in lung morphogenesis associated with macrophage tissue ablation. Keeping in mind that 
macrophages support angiogenesis during organ development and remodelling, we assessed 
vessel density on lungs, by immunohistochemical analysis of CD31 endothelial cell marker. At 
P0, lungs from Csf1r-/- mice presented a significant decrease in vessel density when compared 
with wild type mice (p value=0.020). This finding demonstrates a deficiency in lung vascular 
network associated with macrophage ablation. Furthermore, we quantified RNA expression levels 
of key angiogenic factors (VEGF-A, Flk-1, Ang-1, Ang-2, Hif-1a and Fgf2) in lung from the different 
mice groups at E15.5, E18.5 and after birth, P0. At E15.5 stage, an up regulation of VEGF-A, Flk-
1, Ang-2 and Fgf2 transcripts was found. At E18.5 a significant reduction of VEGF-A and Ang-2 
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RNA levels was demonstrated in Csf1r+/- and Csf1r-/- groups when compared with wild type lungs. 
However, the opposite trend was observed in P0 knockouts lungs, with an increase in VEGF-A, 
Flk-1, Ang-1 and Ang-2 transcripts expression levels. This could be explained by compensation 
mechanisms trying to reverse the deficient lung vasculature (less vessels) observed at P0. In 
conclusion, all these evidences demonstrate that macrophage ablation is critical to lung 
development, impairing airway epithelial and vascular compartments.
xi 
 
Resumo 
 
Os macrófagos estão presentes em quase todos os tecidos desde a fase embrionária até 
à fase adulta, associados a funções tróficas durante o desenvolvimento. Em órgãos como 
cérebro, rim, glândula mamária e pâncreas, os macrófagos estão presentes em largo número, 
regulando o desenvolvimento da sua forma e maturação. A literatura  tem demonstrado que  
processos da morfogénese do  desenvolvimento como a ramificação e a formação do sistema 
vascular são altamente regulados pelos macrófagos. E o pulmão é também um órgão de 
ramificação, dependente da inter-ligação entre a componente epitelial e endotelial. Durante o 
desenvolvimento fetal deste órgão, os macrófagos representam cerca de 2 a 5 % do número total 
de células, permanecendo por identicar qual a sua relevância. Neste sentido, o objectivo deste 
trabalho foi perceber se e como a deleção dos macrófagos influência o desenvolvimento fetal e 
neo-natal do pulmão, usando um modelo de ratinho com a ablação dos macrófagos (Csf1r-/- 
ratinho). O nosso primeiro alvo de estudo foi caracterizar a morfologia dos pulmões que provêm 
de animais Csf1r-/- por comparação com os Csf1+/- e a estirpe selvagem. Desse modo, recorremos 
a análises esterológicas para calcular a densidade de volume (DV) de uma série de parâmetros  
como mesênquima, epitélio,  espaço aéreo, em pontos específicos do desenvolvimento; no 
estadio pseudoglandular (desenvolvimento embriónico (E) 15.5), fetal sacular (E18.5)  e pós-
natal sacular (depois do nascimento, P0). A tendência observada sugere que os pulmões dos 
ratinhos Csf1r-/- e Csf1r+/- apresentam um aumento da densidade de volume de mesênquima 
quando comparado com o grupo controlo em todos os estadios. Especificamente a E 18.5,  para 
além da densidade de  volume de mesênquima estar aumentada, um decréscimo do epitélio e 
espaço aéreo foi observado para os Csf1r-/- animais. Por último, logo após o nacimento (estadio 
P0), os  animais Csf1r-/- apresentaram uma diminuição da DV do epitélio bronquiolar e do espaço 
aéreo comparando com a estirpe selvagem. Estes resultados sugerem um atraso na morfogénse 
pulmonar associado à deleção dos macrófagos tecidulares. Por outro lado, a regulação dos 
macrófagos no processo angiogénico durante o desenvolvimento e no processo de remodelação 
dos vasos, suportou o seguinte foco de estudo. Nós analisamos a densidade dos vasos 
pulmonares, utilizando o marcador endotelial CD31, por imunohistoquímica. A P0, os pulmões 
dos animais com o genótipo Csf1r-/- apresentaram um decréscimo significativo comparado com o 
grupo controlo (p=0.020). Estes resultados demonstram uma deficiência na rede vascular 
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associado com a ablação dos macrófagos. Mais, avaliamos os níveis de expressão de RNA de 
factores angiogénicos chave como VEGF-A, Flk-1, Ang1, Ang2, Hif-1a e Fgf2, nos pulmões dos 
diferentes grupos de animais, a E15.5, E 18.5 e P0. A E 15.5 um aumento de VEGF-A, Flk-1, 
Ang-2 e Fgf2 foram encontrados. A E18.5, um decréscimo nos niveis de expressão de VEGF-A e 
Ang-2 para os animais Csf1r+/- and Csf1r-/- foi demonstrado. Mas quando avaliamos estes factores 
no estadio P0, um aumento significativo de VEGF-A, Flk-1, Ang-1 e Ang-2 foram encontrados 
comparando com o grupo controlo. Este resultado pode dever-se há existência de mecanismos 
compensatórios que tentam reverter a dificiente vasculaura (menor número de vasos) a P0. Em 
conclusão, estas evidências demonstram que a deleção dos macrófagos é critica para o 
desenvolvimento do pulmão, resultando no dano do epitélio das vias aéreas e da vasculatura.  
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1. INTRODUCTION 
 
1.1. Lung development  
 
Lung development is a highly regulated process. Its development is coordinated from the 
primary bud stage until the generation of millions of alveolar gas exchange units [1]. This process 
arises from embryogenesis and continues after birth which involves structural organization and 
functional maturity [2]. Gas exchange allows the oxygenation of red blood cells in the circulatory 
system and the simultaneous removal of carbon dioxide, being one of the most important 
characteristics of respiratory system [3]. Until the lung is fully capable to play this process a 
complex development program should take place. Mammalian lung development starts with the 
differentiation of ventral foregut endoderm into various epithelial cell types that contour the inner 
surface of the trachea and two primary buds, the primordial lung[4]. The endoderm gives rise to 
multiple resident epithelial cells and the mesoderm to vascular structures, airway smooth muscle 
and others [5]. After the primary lung buds formation, the two main bronchi of the primordial 
lung extend into the surrounding mesenchyme and begin the process of branching 
morphogenesis [1, 6]. The two main bronchi of the primordial lung are subdivided into 
sequentially finer buds, the bronchioles, which are surrounded by parabronchial smooth muscle, 
originating the common respiratory tree. This process is essential to elaborate the orchestration 
of the bronchioles and their endings, alveoli, highly specialized structures that allow gas exchange 
process. The branching program of the lung epithelium is accompanied at the same time by the 
development of the pulmonary vasculature, constituted by a blood vessels network, which covers 
the alveoli [1, 4]. It is the tight connection between the airways and the blood vessels the key for 
dynamic and complex respiratory process, which allows an efficient gas exchange.  
1.1.2 Mouse and Human lung developmental stages 
In Humans, the initiation of pulmonary development arises as a bifurcation at the 
posterior end of the laryngotracheal groove, occuring at 3-4 weeks of gestation. In rodents, the 
two buds that will originate right and left lung arise from the foregut endoderm, appearing on 
embryonic day (E) 9.5 of embryo development [2, 7]. Each lung bud develops into left and right 
lungs  [2]. In both, humans and mice, lung constitution is asymmetrical. In humans, left lung 
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comprises two lobes while the right lung consists of three lobes. On the other hand, the left mice 
lung presents a single lobe and the right lung is composed of four lobes [6]. 
In both species, the embryological development of respiratory system can be divided into 
five principal stages (figure 1). In mouse, the first stage corresponds to lung primordium 
appearance (E8-9); followed by pseudoglandular stage, during which the primary buds generate a 
complex tree-like structure (E10-16); canalicular stage, where the terminal buds become 
narrower (E16-18); saccular stage, which involves the developing of numerous small sacs that 
are the precursors of the alveoli (E18.5 to postnatal day (P) 5); and lastly, alveolar stage (starts at 
birth and extends almost 4 weeks into postnatal life) associated with the increase of terminal 
saccules, alveolar ducts, and alveoli. In human embryos, during the embryonic period a 
pulmonary protuberance containing two buttons develops, with the formation of the trachea and 
bronchus (3-4 weeks); pseudoglandular period, during which organogenesis occurs allowing the 
complete formation of bronchial tree and the airways (5-17 weeks); canalicular period, when 
respiratory bronchiole appears and vascular network increases (16-26 weeks); saccular period, 
with expansion of air spaces (24-38 weeks) and alveolar period, when alveolar development 
occurs by the formation of secondary and tertiary septa (36 weeks-2years). For human the first 
four stages take place in utero and the last ends after birth. In mice, the fourth stage ends after 
birth and the last occurs exclusively after birth [1, 2, 8]. 
 
 
Figure 1.  Principal stages of lung development in mouse and human: diagrammatic representations of the timeline 
and developmental organization (adapted from[9]). 
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1.1.3. Cellular Differentiation of the Lung 
 
In mice, the current model of epithelial development describes that airway branching 
morphogenesis occurs during the pseudoglandular stage. The terminal buds contain a pool of 
highly proliferative multipotent progenitor cells, which give rise to several types of cells [1]. The 
differentiated airway tree is composed by a complex and large number of cells, which change 
significantly along the proximal-distal regions (figure 2). In adult mice, the proximal 
pseudostratified epithelium, composed by large airways (tracheobronchial region) shows three 
major cell types: ciliated, basal and clara secretory cells. Ciliated cells are first detected in the 
trachea and mainstem bronchi at approximately E14, being typically marked by expression of 
FoxJ1 transcription factor. Basal cells are observed in the trachea at E10.5 associated with 
expression of the transcription factor Trp63. Clara cells are typically marked by synthesis of the 
secretoglobin family member Scgb1a1, (also known as CC10 or CCSP), which appears around 
E17 [1, 10, 11]. Concerning distal columnar epithelium, composed by small airways (intralobar 
bronchioles), the cell population is similar to the large airways, with no basal cells and more 
number of ciliated cells, neuroendocrine cells and Clara cells.  Neuroendocrine cells are among 
the first cells to differentiate within the respiratory epithelium, with the starts of Dll1 expression at 
E13.5[1] [10]. During the canalicular and saccular stages, the terminal or acinar tubes narrow 
and give rise to small saccules and the walls of these sacs, the primary septae.  
 
  
 
 
Figure 2. Cell types of the respiratory system. (a) Large airways (tracheobronchial region) are covered by a 
pseudostratified epithelium composed of basal cells, ciliated and secretory cells. (b) Small airways (intralobar 
bronchioles) a columnar epithelium containing ciliated, neuroendocrine and Clara cells. (c) The alveoli are composed 
by epithelial type 1 cells (AEC1) and cuboidal AEC2 cells and few cells secreting secretoglobulina Scgb1a1 
(asterisks). The alveolar epithelial cells are closely associated with mesenchymal cells such as fibroblasts, 
endothelial cells and pericytes[10]. 
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The endoderm begins to differentiate into the two main specialized cell types: type 1 and type 2 
alveolar epithelial cells (AEC1 and AEC2) [10]. The type 1 cells constitute about 95% of the 
alveolar epithelium and lining the alveolar saccules, characteristically express aquaporin 5 and 
T1alpha. The type 2 cells comprise 5-10% of the alveolar surface and are characterized by 
production of surfactant-associated protein C (Sftpc or SPC) [5, 7]. Alveolar epithelial cells are 
closely associated with mesenchymal cells including fibroblasts, vascular smooth muscle cells, 
endothelial cells, vascular pericytes and macrophages [1]. 
1.1.4. Development of the Pulmonary Vasculature 
 
The vascular development takes place throughout lung development with alterations in 
the structure of the capillary network. During mouse development, the vascular network of the 
lung is established from E≈10.5 and remains to develop postnatally. This system is composed of 
endothelial cells surrounded by vascular smooth muscle, pericytes, and other mesenchymal 
cells. All these cellular components are specifically organized to ensure the precise function of 
pulmonary vascular system [12]. Particularly, inhibition of lung endothelial cell development is 
accompanied by inhibition of airway epithelial cell differentiation and maturation [13]. Moreover, 
although significant airway remodeling occurs postnatally, the primary vascular network is 
established early in development, being essential for viability at birth [12]. Therefore, the 
crosstalk between the developing vasculature and the developing airways is a key event during 
lung development.  
The angiogenesis and vasculogenesis are the crucial processes, which allow the lung 
vascular development since early stages [13]. Vasculogenesis is characterized to take place at 
early stages of embryo development, with a formation of new blood vessels de novo. On the other 
hand, angiogenesis promotes blood vessel formation from extension of pre-existing ones [14].  
Concerning molecular players of pulmonary vasculature development, the pathways 
VEGF/VEGFR, Angiopoietin/TIE, Ephrins/Eph receptors, and Notch/Jagged appear to be 
essential in the regulation of pulmonary vascularization [15]. For instance, Ephrin B2 expressed 
by the microvasculature is critical for lung alveolization and secondary septae formation [16] 
[17]. Little is known about angiopoetins (Ang) expression during development, but for instance, 
overexpression of Ang-1 causes severe pulmonary hypertension and is increased in lungs from 
human patients with pulmonary hypertension  [18]. Regarding Notch/Jagged pathway, for 
instance Notch-1 and Jagged-1 gene expression increased progressively from early to later lung 
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development, on vascular and nonvascular cells, suggesting their contribution during lung 
development. [19]. VEGF-A/VEGFR-2 signaling is a crucial pathway, which regulates physiological 
and pathological lung formation. This pathway has central action on vascular system, as a 
mitogen, survival, and differentiation factor for endothelial cells [20]. However, their relevance 
has been also demonstrated in pulmonary epithelial morphogenesis. For instance, in neo-natal 
mice, the neutralization of VEGF-A or VEGFR-2 (Flk-1) leads to a lung immature with less complex 
alveolar [21].  
Furthermore, using mouse embryonic lung cultures treated with an antisense 
oligodeoxynucleotide to the VEGFR-2 was observed the loss of VEGF function which leads  to a 
decreased in epithelial branching, epithelial and mesenchymal proliferation, and a 
downregulation of BMP-4 expression, an important regulator of lung development [22]. On the 
other hand, VEGF-A stimulation increases epithelial branching morphogenesis on lung embryonic 
cultures with an increases of Sp-c as well as Bmp-4 mRNA levels [22]. VEGF-A hyper expression 
in respiratory epithelium mice leads to lung vasculature alteration associated with disruption of 
the lung acinar structure, branching morphogenesis and inhibition of Type I cell differentiation  
[23].  These observations indicate that lung morphogenesis is critically dependent on lung 
neovascularization and VEGF/ VEGFR-2 pathway plays a key role in lung patterning.  Together all 
these evidences demonstrated the close link between airway and vascular development, since 
the disruption of one system has critical consequences on the development of the other, and the 
other way around. 
 
 
1.2. Macrophages 
1.2.1. Macrophage origin and differentiation  
Macrophages belong to the mononuclear phagocyte system (MPS). It includes bone-marrow-
derived precursor cells, monocytes present in the peripheral blood and mature macrophages 
existent in the tissues [24]. Macrophages are normally identified in murine tissues using the 
markers, CD68, F4/80 and/or CD11b [25]. CD68, whose expression is restricted to 
mononuclear phagocytes, is a lysosomal antigen expressed (at high levels) in 
monocyte/macrophages [26]. F4/80 is a well-characterized membrane protein and the best 
known marker for mouse macrophages and blood monocytes [27]. CD11b is a leukocyte-specific 
receptor and is regarded as a marker for monocyte/macrophages, granulocytes, and natural 
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killer cells[28] In mice, the first population of macrophages is found in the late head-fold stage at 
E7.5 and has maternal origin [29]. However, the first embryonic macrophages, which derive from 
the primitive endoderm of the yolk sac, are found at E8 and sprout to the anterior structures of 
the embryo and don’t express mature macrophage markers, such as F4/80. These 
macrophages don’t differentiate from monocyte cells but directly from mesenchymal progenitor 
cells [30]. The first site of definite haematopoiesis is the yolk sac, followed at E10 by the aorta–
gonads–mesonephros region of the embryo, where the second pool of hematopoietic progenitor 
cells and F4/80 positive cells are found [31-33]. By E10.5 to E11 the primitive liver becomes the 
principal site of haematopoiesis and from this moment, macrophages that have differentiated 
from monocytic progenitor cells colonize the entire embryo [32, 33].  After birth, the bone 
structures are formed and the bone marrow becomes the main site of haematopoiesis and the 
MPS is established [34]. Macrophages derive from pluripotent hematopoietic stem cells under 
the influence of numerous factors. The bone marrow stem cells (BMSCs) differentiate in multiple 
macrophages progenitor stages: from granulocyte/macrophage colony-forming unit (GM-CFU) to 
macrophage CFU (M-CFU) to monoblast to pro-monocyte and for last macrophage [24]. 
Transcription factors as PU.1 are important to macrophage differentiation. However, this is 
required only for macrophages differentiation from monocyte precursor, once PU.1-deficient mice 
is normal until the macrophages differentiation through the monocyte precursor starts [35] [32]. 
However, others factors are necessary for the differentiation of each macrophages cells 
precursors. The production of macrophages by the liver, and then by the bone marrow, is 
controlled in large part by the growth factor macrophage colony-stimulating factor (CSF-1). This 
growth factor allows the differentiation of macrophages from monocytes as well as their 
proliferation and viability in vitro [24]. Circulating CSF-1 is produced by endothelial cells in blood 
vessels and, together with locally produced CSF-1, regulates the survival, proliferation and 
differentiation of mononuclear phagocytes and osteoclasts (figure 3) [36].  
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Figure 3. Macrophage origin and differentiation. Progenitors cells of MPS system arise from bone marrow, 
where from pluripotent stem cells (PPSCs) others progenitor are formed. The multipotent progenitors are 
granulocyte/macrophage colony-forming unit (GM-CFU), which differentiate in monoblast and this last in pro-
monocyte. In blood vessels, endothelial cells produce CSF-1, which allows the differentiation of pro-monocyte coming 
from the bone marrow in monocytes. In the tissues, local produced CSF-1 allows the differentiation of monocytes in 
tissue macrophages. (Adapted from [24, 36])    
 
1.2.2. CSF1/CSF1R Pathway 
Csf-1 acts on its target cells by binding to colony stimulating factor 1 receptor (Csf1r), a 
cell-surface tyrosine kinase receptor expressed in macrophages and all trophoblast cell lineages 
[31]. The activation of this pathway is allowed by the link of Csf1 to the receptor Csf1r, which 
triggers their autophosphorylation and successive phosphorylation of downstream molecules. 
Phosphorylation of most of tyrosine residues creates docking sites for a variety of signaling 
molecules such as the p85 regulatory subunit of phosphatidylinositol 3-kinase (PI3K), Casitas B 
lineage (Cbl) and Grb2-associated binder-3 (Gab3), to mediate macrophage survival, 
differentiation, morphology and motility (Figure 4) [37-39]. Beyond Csf1, macrophages can also 
be grown and differentiated from monocytic progenitors in the presence of GM-CSF and to a 
lesser extent under the action of IL-3. The double action of these two factors allows the 
generation of mature macrophages [40, 41]. Mice with null mutation in the Csf1 gene or with 
null mutation in Csf1r are both deeply depleted of most macrophage populations. However, these 
mice are not totally depleted of macrophages, as is the case of spleen resident macrophages, 
thymus and lymph nodes derived-macrophages [36, 42]. 
Nevertheless, Csf1 and Csf1r phenotypes mutant animals, together with PU.1 are the best 
models to study the trophic roles played by tissue macrophages [24]. The phenotype of the PU.1 
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knockout is characterized by the depletion of B cells and granulocytes and also a significant 
decrease in the size of many macrophage populations [24]. The phenotypes found in Csf1 and 
Csf1r mutant mice are similar, which means that Csf1r is the only receptor for Csf1. However, 
the severity of some phenotypes is more evident in Csf1r-/- mice, which rarely live beyond a few 
weeks of age. The phenotypes include complete loss of epidermal Langerhans cells and 
microglial cells. Conversely, these populations of cells are relatively normal in the Csf-1op/op mice. 
This could be explained by the existence of other ligands that could link to the Csf1r, as IL-34, 
which supports myeloid-cell development in vitro [43].  
 
Figure 4. CSF1/CSF1R Pathway. Colony-stimulating factor-1 receptor (Csf-1r) activation leads to regulation of 
different signaling pathways in myeloid cells. CSF1 binding to CSF-1R kinase triggered its tyrosine phosphorylation 
and generate the activation of signaling molecules associated with the receptor through their phosphotyrosine-
binding domains [36].   
1.2.3. Macrophages subsets  
Macrophages display functional plasticity, which allows their polarization in a diversity of 
subsets (figure 5). The microbial and cytokine environment drives macrophages to express 
specialized and polarized functional properties allowing their wide functional heterogeneity [44]. 
Several macrophages subsets with distinct functions have been described.   
Macrophage activation can be either pro-inflammatory or anti-inflammatory leading to tissue 
damage or renewal and wound healing [45]. Classically activated macrophages, designated as 
M1, mediate defense of the host from intracellular pathogens, being activated by 
lipopolysaccharide and interferon- γ. These macrophages are commonly characterized by 
interleukin (IL)–12high, IL-23high and IL-10low phenotype. They express pro-inflammatory cytokines 
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such as IL-12, IL-23, IL-1beta, IL-15, IL-18 and TNFalpha, which are involved in the T helper 1 
(TH1)-cell-mediated immune resolution of infection. They also produce chemokines and abundant 
amounts of reactive oxygen and nitrogen intermediates [44, 45]. Functionally, M1 cells enhance 
endocytic functions and improve the capacity to kill intracellular parasites [46, 47].  Alternatively 
activated macrophages, defined as M2, have anti-inflammatory function, enhance debris 
scavenging, angiogenesis, wound healing, tissue remodeling and repair [24]. They are involved in 
processes such as extracellular matrix (ECM) production and release of trophic factors. M2 cells 
have been described in a number of variants, depending upon the stimuli used to generate them. 
These cells generally share an IL-12low, IL-23low, IL-10high phenotype; have high levels of scavenger, 
mannose and galactose-type receptors. They ensure the  production of ornithine and polyamines 
through the arginase pathway and are IL-1 receptor antagonist (IL-1ra) high, IL-1decoyR high, IL-1blow 
and caspase1low [48]. They can be subdivided in M2a, stimulated by type II cytokines IL-4 or IL-13; 
M2b, obtained by triggering of Fcgamma receptors in the presence of a Toll receptor stimulus; 
and M2c which includes deactivation programs elicited by GC, IL-10 or TGFbeta [45]. The 
different types of macrophages are specified by the microenvironment, although there is 
considerable plasticity between distinct types. These two distinct profiles show that the 
macrophage activation can be either pro-inflammatory or anti-inflammatory, contributing to tissue 
destruction or regeneration. The diverse macrophages functionality has contributed to 
demonstrate their tissue trophic role namely through their implication in pathology [49]. 
 
 
Figure 5. Macrophage activation and polarization. Within the tissue, monocytes can polarize in M1-type, 
classically activated macrophages, when it’s exposed to pro-inflammatory cytokines such as TNF-α and IFN- γ or 
LPS. And these macrophage populations are characterized by high production of pro-inflammatory cytokines such as 
TNF-, IL-6, IL-12, IL-15 and IL-23. On the other hand, when monocytes are stimulated by IL-4, IL-13 or IL-10, they 
generate alternative activated macrophages (M2-type), which produce low levels of pro-inflammatory markers and 
high levels of anti-inflammatory mediators such as IL-10, IL1ra and TGF- β[50]. 
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1.2.4. Relevance of Tissue Macrophages 
 
In mammals, macrophages are found throughout the body tissues (figure 6). They are 
strategically located to answer inflammatory conditions, being able to ingest and process external 
materials, dead cells and debris and call for additional macrophages [24]. 
 
Figure 6. Distribution of body tissue macrophages. Macrophage precursors are released into the circulation 
as monocytes and then migrate into all body tissues, differentiating into mature macrophages. They are strategically 
located throughout the body where they have specialized functions [51]. 
 
Based on their anatomical localization and functional phenotype, macrophages are divided into 
subpopulations of mature tissue macrophages [24, 49].  Tissue-resident macrophages comprise 
osteoclasts (bone), alveolar macrophages (lung), histiocytes (interstitial connective tissue), 
Kupffer cells (liver), among others[49]. The levels of macrophages in these tissues are variable. 
For instance in microglial cells in the brain and Kupffer cells in the liver they constitute 10–20% 
of all cells , but in other tissues their levels are low, such as at the musculo–skeletal junctions 
[52, 53]. Besides the recognized function of macrophages in disorders induced by pathogens, it 
is being increasingly accepted that they also have unique non-pathogen induced functions in 
tissue homeostasis, remodeling and reorganization. Higher levels of macrophages are present in 
almost all developing organs, with a spike correlated with key periods of organogenesis [54]. 
Among other functions, macrophages are crucial in processes such as branching 
morphogenesis, neural patterning, angiogenesis, bone morphogenesis and the generation of 
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adipose tissue [24]. They are fundamental in the normal development of several organs, as the 
mammary gland, pancreas and kidney, and the development of these organs is mainly 
characterized by branching morphogenesis, which is decisive during lung organogenesis [31, 55, 
56]. In all these cases, the macrophage depletion leads to tissue impairment formation, 
responsible by their inadequate function. 
 
1.2.4.1. Bone morphogenesis 
Analysis of spontaneous mouse mutants or mice with experimental gene disruptions has 
highlighted key steps in the differentiation and activation of osteoclasts. Specifically, the use of 
CSF-1op/op mice determined that the ablation of CSF1 results in a defective development of a 
common monocyte-osteoclast bone marrow progenitor cell. This progenitor cell under the 
stimulus of the receptor activator of nuclear factor-kB ligand (RANKL) becomes a multi-nucleated 
functional osteoclast (figure 7)[57].  
 
 
 
 
Figure 7.  The trophic role of macrophages in bone morphogenesis. The formation of monocyte- osteoclast 
progenitor is dependent of Colony stimulating factor 1 (CSF1) in the bone marrow that then proliferates and 
differentiates in the presence of receptor activator of nuclear factor-κB ligand (RANKL) give arise to multinuclear 
osteoclasts[24].  
The most striking phenotype of CSF-1op/op mice is osteopetrosis, with skeletal abnormalities and 
tooth eruption failure due to osteoclasts depletion. This phenotype is also common in Csf1 -/- rats 
(known as toothless rats; tl rats) and PU.1-deficient mice that reveal early myeloid defects and an 
impaired development of both macrophages and osteoclasts [42, 58, 59]. CSF1 is also 
responsible to enhance mature osteoclastic bone reabsortion [60]. Remodeling of bone occurs 
throughout adult life and is controlled by the interaction of bone marrow stromal 
cells/osteoblasts and osteoclasts. Without functional osteoclasts, the normal re-sculpted of bone 
doesn’t happen, leading to osteopetrosis. Osteopetrosis causes the fail in the marrow cavity 
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orchestration, which leads to ablation of the most part of haematopoiesis that normally occurs in 
the bone marrow, although still occurs extramedullary hematopoiesis in the liver and spleen [61]. 
Csf1op/op mice also show the absence of teeth because the tooth buds, although formed, cannot 
erupt through the jaw [42, 59]. This osteopetrotic phenotype is one of the best examples of the 
irreplaceable function of specialized macrophages and their tissue-trophic role. 
1.2.4.2. Mammary gland development  
Macrophages are an important component of the mammary gland stroma and the ablation of 
this cell population results in defective ductal elongation, decreases fibroblast growth factor 
(FGF)-induced mammary epithelial proliferation, suggesting their direct or indirect actuation in 
mammary epithelial proliferation [62, 63]. This fact could be explained because several cell 
types, including epithelial, fibroblasts, adipocytes and endothelial cells, composing the mammary 
gland, and macrophages are known to interact [55].   In mice, the initial mammary ducts give 
place to multilaminate bulbous termini called terminal end buds (TEBs) [24]. At the same time 
that TEBs begin to grow during puberty, macrophages are recruited and align along the neck of 
the TEB structures and their presence is critical for proper ductal elongation (figure 8). 
 
 
Figure 8. The trophic role of macrophages in ductal branching. Macrophages are associated with epithelial 
structures including terminal end buds (TEBs) and are often associated with collagen fibres, which they help to form. 
Loss of macrophages results in defective ductal elongation and disrupts collagen fibrogenesis [24]. 
 
Studies in CSF-1op/op mice demonstrated the correlation between macrophages action and 
mammary development. These mice showed a decrease in ductal elongation associated with the 
fact that macrophages were not recruited to the TEB structures and the rate of outgrowth of 
these structures and their branching was decreased [64]. On the other hand, the cross of  these 
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mice to transgenic mice overexpressing CSF-1 under the control of the mouse mammary tumor 
virus (MMTV) promoter overcame the atrophic mammary gland, meaning that this effect is due to 
local production of CSF-1 rather than a systemic effect [65]. Although the mechanism of 
macrophage activity remains not fully understood, the formation of collagen fibrils but not 
collagen I synthesis is inhibited in CSF-1op/op mice. The restoration of macrophage activity results in 
the formation of normal fibrils and normal ductal outgrowth and branching, being evident the 
relevance of macrophage in matrix remodeling of mammary gland [66]. It is accepted that 
different populations of macrophages may exist in mammary gland and these populations may 
reside at different levels of M1/M2 with actions dictated by external stimuli. 
 
1.2.4.3. Neural networking/Reproductive system  
 
Macrophages are found throughout reproductive tissues [67]. In this way, one of the 
approaches to determine their role, using CSF-1op/op mice, shows severe defects in the 
reproductive system. One of the implications is associated gonadal tissue. In male mice, 
macrophages are closely associated with testosterone- producing Leydig cells in the testis, and 
their ablation using a liposome encapsulated clodronate suppress testosterone synthesis. Female 
mice shows poor ovulation rates, since that macrophages are recruited to the interstitium of the 
developing ovarian follicle, and the maximum number of these cells is present before ovulation.  
Nevertheless, analyses of CSF-1 nullizygous mice suggest that the primary reproductive defect 
occurs in the regulation of the hypothalamic-pituitary-gonadal axis [24]. In male mice, the 
concentration of circulating luteinizing hormone (LH), which is the pituitary hormone responsible 
for testosterone biosynthesis, is reduced by 90% compared to control mice [68]. To determine 
whether this was due to a primary defect in the pituitary, CSF-1op/op mice were treated with the 
GnRH agonist, histrelin, and the levels of circulating LH were rescued [68]. These data suggest 
that CSF-1op/op male mice have a primary defect in their hypothalamic axis. In female, there is also 
decreased negative feedback response to oestrogen removal and a full absence of the positive 
feedback to oestrogen that causes the surge in LH, resulting in impairment of the ovulation [24]. 
These evidences are consistent with the relevance of macrophages during the development and 
maintenance of reproductive system and neural networking. 
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1.2.4.4. Brain 
 
In the brain the number of macrophages is large, known as microglial cells, which represent 
around 15 % of total value of brain cells. These cells seem to be the only ones that express 
CSF1R in the brain during development and in adult-hood [53, 69]. The brain of CSF-1op/op mice is 
grossly normal, with unremarkable cytoarchitecture, and microglia appear to be normal in the 
adult, but these animals shows a small development delay in their acquisition [70, 71]. On the 
other hand, in CSF1r-/-  mice there is a complete absence of microglia population, resulting in 
strong defects in brain such as swollen ventricles, thinned cortex and decrease in olfactory 
bulbs[72]. This different phenotype could be explained by the IL-34 action, acting as an 
alternative ligand for CSF1R. In vitro studies of rat embryonic brains, the CSF1 treatment induced 
outgrowth and neuronal survival in mixed cultures but not in pure neuronal cultures [73]. 
Although the precise molecular base of microglial cells in brain remains unknown, it is instructive 
the relevance during wound repair orchestration after brain injury [74]. For instance, in 
paraplegic rats the macrophage implantation is followed by a regeneration of spinal cord, and in 
ischemia model the selective ablation of microglial cells exacerbates ischemic injury in the brain 
[75]. Microglial cells have been recognized to produce growth factors, such as insulin-like growth 
factor 1 (IGF1), neurotrophic and protective factors [24].  These data shows the relevance of 
macrophages in the establishment of neuronal circuitry during development. 
 
1.2.4.5. Angiogenesis  
 
Macrophages have been recognized as important players of angiogenesis during wound 
healing, producing a variety of factors that can regulate vascular potential [24].  However, only 
more recently their relevance in developmental angiogenesis has been explored. During eye 
development, the role of macrophage in vascular remodeling was showed. Macrophage ablation, 
either using a suicide gene approach or through their loss in PU.1-deficient mice, results in a 
failure of remodeling and persistence of the eye vascular deficient structure post-natally [76]. The 
mechanism of macrophage action is through their production of WNT7B, which stimulates 
neighboring vascular endothelial cells to enter the S phase of the cell cycle. More, the action of 
Ang-2 produced by pericytes leads to endothelial cells undergoes apoptosis to be phagocytosed 
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by the macrophages (figure 9) [77, 78]. Therefore, macrophages allow that the vascular 
remodeling occurs, and ensures the phagocytosis of apoptotic endothelial cells.  
 
 
Figure 9. Macrophages interference in angiogenic and vascular eye development. The hyaloid vessel 
system remodeling is dependent of the vessels synthesize WNT7B, which leads to vascular endothelial cells to enter 
the DNA synthesis phase of the cell cycle.  And the angiopoietin 2 (Ang-2), produced by pericytes blocks the survival 
signal from Ang-1, which allows that the endothelial cells suffering apoptosis are phagocytosed by the macrophages 
[24].  
  
In brain development was shown that these cells promote vascular networking and this effect 
appears as being due to an interaction with endothelial tip cells. This association was observed 
during all phases of vascular networking formation. Also it was showed that yolk sac–derived 
macrophages colonized the embryonic mouse brain independently of vessels, as previously 
reported for the chick macrophages accumulated in the subventricular zone (SZ) between E 10.0 
and E 11.5. From this moment, the vessels began to sprout laterally and fused with neighboring 
vessel branches to form the subventricular vascular plexus. Furthermore, the number of 
macrophages in the SZ peaked at E 11.5, the major phase of vascular networking. The ablation 
of macrophages using PU.1-null mice results in hindbrains   with significant reduction in the 
number of vessel intersections and thereby decreased subventricular vascular plexus (SVP) 
complexity. Fewer connections also formed between neighboring radial vessels compared with 
wild-type hindbrains at the time when vascular networking was initiated in deeper brain layers. 
CSF1- deficient hindbrains had an SVP with reduced complexity, similar to PU.1-null mice [79]. 
These findings suggest that early tissue macrophages play an essential role in brain 
angiogenesis. 
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1.2.4.6. Pancreas  
       In the primary postnatal pancreas of different mouse strains, mature macrophages have 
been detected from birth on. The number of F4/80 positive cells significantly decreases from 
birth to weaning. This fact could be explained by the exocrine expansion associated with the 
postnatal development of the pancreas, but can also mean the earliest F4/80 fetal macrophages 
disappearance. Despite the critical influence of macrophages in the development and 
pathogenesis of diabetogenesis, as a result of their infiltration in intra-islet, they have not been 
clearly described in noninflamatory conditions. Under physiological conditions, the 
characterization of macrophage population was performed, and macrophages were first observed 
in the pancreas at E14.5 and remain present in the fetal pancreas at E17.5. It was also observed 
the presence of macrophage precursors at E12.5 in the fetal pancreas, pancreatic buds along 
with stomach and duodenal loops [56].  The F4/80+ cells, observed at E14.5, do not likely enter 
the pancreas via blood circulation, since that functional blood vessel are not observed until E15.5 
in the murine pancreas [80].The association between macrophages and tissue organogenesis 
was described. In vivo studies demonstrated that macrophage ablation results in abnormal 
postnatal islet morphogenesis and impaired pancreatic cell proliferation [81].   Pancreatic 
explants were excised and cultured with or without M-CSF.  F4/80+ cells were observed in the 
explants, for both cases, after 5 days of culture. However, the supplementation with M-CSF 
induced a significant increase in the number of F4/80+ cells in the explant area. Also, it was 
examined that the addition of M-CSF, and the consequent increase in macrophage number, 
increase more than fourfold the number of positive insulin cells (insulin- and glucagon-expressing 
cells) in the cultured explants. Possibly, this effect is mediated via differentiation and activation of 
the macrophage precursors that were present in the explant [56]. These results allowed 
concluding an important role in the development of fetal pancreas macrophages. 
 
 
1.2.4.7. Kidney  
Fetal macrophages are among the first hematopoietic cells found in the kidney, appearing in 
the renal interstitium between E11.5 and 12. It was demonstrated the co-localization of F4/80 
with Csf1r-positive cells in the interstitium surrounding the ureteric bud, using a Csf1r-EGFP 
mice. Their localization appears to be contiguous to the vascular development bed between the 
metanephric mesenchyme and the metanephric ducts, suggesting that possibly macrophages 
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enter the renal mesenchyme from or with the circulation. The supplementation with CSF-1 to 
E11.5-12 kidney explants culture resulted in a significant increase in the number of branch tips 
and nephrons [31]. Associated with this effect was showed the increase in EGFP-positive cells as 
a result of an increase in the macrophage population. However, there are several ways to the 
CSF1 actuation in the kidney development, such as macrophage response with the production of 
critical factors, as growth signal mediating surface tethered, or transmembrane proteins able to 
signal to adjacent renal cells. Other effect could be an increase in the clearance of apoptotic cells 
due to macrophage activation. However, apoptotic markers in the explants are not significant 
different with or without CSF-1 stimulation. Other possibility is the CSF-1 effect in the number of 
resident macrophages, which increases the proliferative environment. Finally, CSF-1 could 
directly signalize to another cell population within the kidney. Rather than an immunological role 
assigned to macrophages, these findings suggest a trophic role during embryonic kidney 
development [31]. During post-natal development, a similar approach was used to identify the 
relevance of macrophages in postnatal organ growth and kidney repair. CSF-1 administration to 
newborn mice increased overall body weight and kidney weight and volume. Moreover, using 
Csf1r-reporter mouse it was showed that this effect was accompanied by an increase in 
macrophage numbers in the kidneys.  
 
1.2.5. Lung macrophages and inflammatory mediators in lung development 
 
1.2.5.1. Lung macrophages 
 
The adult lung macrophage population could be subdivided in two principal types: 
alveolar and interstitial macrophages, localized in separate anatomical compartments in the lung, 
including the air spaces and lung connective tissue, respectively [82, 83]. Alveolar macrophages 
are localized within the alveolus, strategically located to answer as primary defense of the lung 
against inhaled particles [84, 85]. Interstitial macrophages are closely associated with matrix and 
connective-tissue of lung, representing around 40% of the total macrophages in lung tissue [86]. 
Interstitial macrophage exhibits a power greater than alveolar to proliferative and this capacity is 
possible related with the maintenance of lung macrophage pool [40]. 
During mice lung development, macrophages are found since the begining of 
development around E10, and remains during throughout development [87, 88]. 
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Immunofluorescence labeling to F4/80 macrophage marker in E12.5 embryonic lungs, showed 
that macrophages are located extensively accumulated within developing lungs, particularly 
within branch points.  At E15.5 the relative abundance of macrophages in lung is around 5% of 
total cells. More, their characterization shows enrichment in a lot of genes common with tumor 
associated macrophages (TAM), suggesting similarities between fetal and tumor environments 
[31]. On the other hand, more recent findings showed that macrophages are closely associated 
with maturation of lung. During the saccular stage at post-natal day (P) 1 and P 5, around 8% of 
total lung cells are macrophages.  The increase of these cells is greater during postnatal 
development, particularly, during alveolarisation, from P 14-21 approaching the 16%, and at 3 
months a significant resident macrophage population is maintained. More, during alveolarization 
it was showed the upregulation of Arginase 1 (Arg1), mannose receptor 1 (Mrc1) and chemokine 
C-C motif ligand 17 (Ccl17), a phenotype of an M2 or tissue remodeling macrophages [88]. 
These facts shows that macrophages are present during all lung development but their levels are 
variable. Despite the deep characterization of macrophage population during post-natal periods 
and to lesser extent during fetal development, the real contribution of macrophages to lung 
development remains unknown. 
 
1.2.5.2. Cytokines as mediators in lung development 
 
Some cytokines commonly secreted or regulated by macrophages have been 
demonstrated to modulate fetal lung branching and maturation [89, 90]. Besides their crucial 
role in inflammation and the immune response, some cytokines are important players in 
hematopoiesis, liver and neuronal regeneration, embryonic development and fertility. Their action 
is mediated by the activation of target genes involved in crucial processes of development such 
as differentiation, survival, apoptosis and proliferation [89]. During lung development, the 
relevance of some cytokines has been described. For instance, IL-6 is constitutively expressed in 
rat pulmonary primitive epithelium, displaying highest levels during earliest stages, which 
decrease during the following stages of development. Also LIF is important during lung 
development. Although Leukemia inhibitory factor (LIF) knockout mice have normal lung 
formation, it is known that LIF, together with insulin-like growth factor I (IGF-I), regulates lung 
maturation. LIF in addition to IGF-I null mutant mice aggravates pulmonary immaturity, namely 
LIF/IGF-I double deficient embryos show lung hypoplasia and defective differentiation of the 
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alveolar epithelium and vasculogenesis. Likewise, TGFβ is expressed at high levels during normal 
lung development, being crucial for branching morphogenesis and epithelial cell differentiation 
with maturation of surfactant synthesis [91].  Other cytokine associated with lung development is 
TNF-a receptor found throughout the embryonic lung and the supplementation with TNF-a in vitro 
of embryonic lung primordial have a stimulatory effect on branching morphogenesis and 
surfactant-associated protein (SP-A) expression [92]. 
  Concerning lung maturation, the overexpression of pro-inflammatory mediators, for 
instance TNF-α, transforming growth factor α (TGF-α), IL-11, or IL-6, in mice lungs results in 
pathologic situations leading to impairment in alveolarization. The overexpression of the 
enumerated factors results in fewer and larger alveoli and fibrosis. [93].  The previous data 
suggests that lung development is highly regulated by cytokine environmental. Being 
macrophages relevant players in cytokines expression, their possible relevance during lung 
development is overwhelming.  
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1.10 Rationale and Aims 
 
Besides their function during the development in other organs, macrophage function 
during lung development remains unknown. Therefore, this master thesis aims to understand the 
relevance of tissue macrophage ablation during lung development. Tacking in account that 
disruption of Csf1r gene results in large depletions of macrophages in most tissues, in order to 
accomplish this aim, we perform a characterization of lung development using a macrophage-
deficient mouse model (Csf1r-/-). Three specifics points of lung development were evaluated: the 
pseudoglandular (at E15.5), the fetal saccular stage (E18.5) and the post-natal saccular stage 
(P0). For all stages tree groups/genotypes Csf1+/+- Csf1r-/+ and Csf1r-/- were compared: 
- At pseudoglandular stage it was performed the evaluation of gross morphology, bud number 
quantification and lung morphology characterization, in which stereological analyses was used. 
For the last evaluation it was used stereological analysis. Specifically, it was measured epithelial, 
mesenchymal and air space volume density (VD). Additionally, it was performed evaluation of 
lung vasculature: vessel density quantification using the endothelial cell marker CD31 (PECAM-
1), by immunohistochemistry. Beyond this, assessment of transcripts expression patterns of 
angiogenic factors and associated molecules (such as VEGF-A, VEGFR2, Ang-1, Ang-2, Hif1α and 
Fgf2) was performed by q-RT-PCR. 
- At the fetal saccular stage (E18.5) it was also evaluated lung morphology by the same 
parameters described. Concerning lung vasculature, beyond the parameters evaluated at E15.5 
stage, it was evaluated the artery thickness, using Weigert’s staining. 
- At post-natal saccular stage (P0), beyond the previous lung morphology evaluation at E15.5 and 
E18.5, lung-to-body weight ratios were accessed. Regarding, stereological analysis, beyond the 
mesenchymal, epithelial and air space volume, it was also evaluated the large and small airway 
epithelium VD. Blood gasometrical evaluation was performed as readout of lung functionality. 
Regarding lung vasculature all parameters evaluated at E18.5 stage were also evaluated.  
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2. MATERIALS AND METHODS  
 
2.1. Animals  
All procedures and protocols were carried out in accordance with European Union 
Directive 86/609/EEC and NIH guidelines on animal care and experimentation. Mice of mixed 
genetic background (C3H/C57BL/6) and deficient in Csf1r (Csf1r–/-) were kindly provided by Prof. 
E. Richard Stanley, Albert Einstein College of Medicine University Yeshiva, Bronx, USA.  Animals 
were fed ad libitum and exposed to day-night cycles alternatively every 12h. 
2.2. Study design  
 
The Csf1r+/- animals were crossed and the vaginal plug checked 12 hours after and 
defined as embryonic gestational day 0.5 (E0.5). At E15.5 and E18.5 stages, dam were 
sacrificed by cervical dislocation, embryos were removed by caesarean section. Embryos and 
newborns (post-natal day (P) 0) were sacrificed by decapitation and lung excised under 
stereomicroscope (Olympus SZX7). Depending on the analysis required, different lung tissue 
processing was performed. To evaluate mice genotype, a small piece of tissue of each animal 
was collected. The tree different embryos/newborns genotypes were assessed using PCR 
analyses. Then, the animals were subdivided into 3 groups: Csf1r+/+ (wild type or control); Csf1r+/- 
and Csf1r-/-. 
 
 
2.3. PCR analyses for Genotyping  
Pellet was diluted in ultrapure H2O and let to dissolve overnight. Detection of CSF1R 
transgene was done using a primer specific to a fragment Csf1r. Genomic DNA was extracted 
from tissue pieces and incubated overnight at 55° in lysis buffer (100 mM TRIS (pH8), 0.2 % 
sodium dodecyl sulfate (SDS), 5mM EDTA) and proteinase K (85μg/ml). After centrifuged 10 min 
at 14000g, isopropanol was added to the supernatants collected, centrifuged 5 min at 14000g, 
the new supernatant discarded and pellet dried by incubation at RT. Pellet was diluted in 
ultrapure H2O and let to dissolve overnight. Detection of Csf1r transgene was done using a set of 
specific primers to a fragment Csf1r. The final concentrations in the PCR reactions were: 50ng of 
extracted DNA, 200 μM of each dNTP, 1.5mM MgCl2, 1.25 U Taq DNA Polymerase (Promega) 
and 0.4 μM of each primers ( Csf1r-Intron 2 Forward: 5’AGACTCATTCGAACCAGAGAGC-3’; Csf1r-
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InEx 3 Reverse: 5’-GAATTTGGAGTCCTCACCTTTG -3’; Csf1R-Neo-Forward: 5’ 
CCGGTAGAATTCCTCGAGTCTA-3’). Amplification (MycyclerTmthermalcycler, BIO-RAD) was 
performed as follows: 92° for 20 sec (initial strand separation); 35 cycles of 94º (20 sec),  58º 
(45 sec) and 72º (1 min); and 72° for 7 min (final elongation step). The PCR fragment size 
expected to presence of Csf1r gene (wild type animals) was 385 bp and to absence (Csf1r-/-) was 
308 bp. These were visualized by electrophoresis in 4% agarose gels. 
2.4. Lung-to-body weight ratios 
 
After birth (P0), newborn were killed by decapitation and lung excised under a 
stereomicroscope.  The right and left lungs and the entire animal were weighed independently 
and lung-to-body weight ratios were assessed. The evaluation was performed to the tree 
genotypes (Csf1r+/+: n=8; Csf1r-/+: n=11 and Csf1r-/-: n=4). 
 
2.5. Neonatal blood gasometric evaluation  
 
The newborn were killed by decapitation and the blood collected (neck bleeding) to 
perform gasometric evaluation. The parameters calculated were: pH, PCO2 (Partial Pressure) 
(mmHg), PO2 (mmHg), SatO2 (Saturation) (%) and Lactate (mmol/L) using a gasometric analyser 
(i- Stat1 analyser; Abbott, Chicago, IL, USA). The evaluation was performed for the tree genotypes 
at P0 stage (Csf1r+/+: n=4; Csf1r-/+: n=5 and Csf1r-/-: n=2). 
 
 2.6. Stereological Analyze 
 
To stereological analyses, the trachea was cannulated and the lungs were insufflated with 
fixation solution (glutaraldehyde 2,5% in PBS) under a constant pressure of 1 rpm during 1 min 
using a peristaltic pump (Gilson, Model Minipul S3).  The lungs were dissected and kept in 
fixation solution on agitation, until its processing. Briefly, the lungs were dehydrated in increasing 
concentrations of ethanol and xylol, embedded in methacrylate, consecutively cut in slides with 
15 µm and stained with hematoxylin-amoniacal.  Stereological analysis was carried out by one 
person, blinded to the genotype of the animal, on a Zeiss microscope Axioplan 2 (Tokyo, Japan) 
using the Stereo Investigator version 5.2 software (MicroBrightField). A fixed range of 30 to 30 
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slides per animal was used; the 15µm-thick hematoxylin stained slides from each animal were 
analyzed using a grid of test points. The total number of points and intersections in each lung 
were >1,000. Morphometric parameters, such as total, mesenchymal, epithelial, air space, 
alveolar and bronchiolar lung tissue volume were calculated according to the point and 
intersection counting. Briefly, all points (intersections) which laid over a point count were counted 
and were represented as a proportion of total points. The volumes were calculate by the Cavalieri 
principle VL = h·∑P(sl)·d2(h- thickness, sI-point number, d-distance between grid points) [94]. The 
percentage of volume density relative to all lung tissue was calculated for Csf1r+/+, Csf1r-/+ and 
Csf1r-/- animals (n=4, n=5 and n=4  lungs were analyzed at E15.5; n=4, n=4 and n=4 at E18.5; 
and n=4 n=5 and n=4 at P0, respectively). 
 
2.7. Immunohistochemistry  
To immunohistochemical studies the trachea was cannulated and the lungs were 
insufflated with fixation solution (paraformaldehyde (PAF) 4% in PBS) without pressure control.  
Then, lungs were dissecated and fixated overnight at RT with agitation. Afterwards lungs were 
dehydrated in increasing concentrations of ethanol and xylol, embedded in paraffin and 3 µm 
slides were used. Briefly, paraffin slides were deparaffinized and rehydrated. Antigen retrieval 
trials were performed in: 10mM of citrate buffer pH=6.0 in microwave or water-bath at 100°C, 
by 15 and 20 min, respectively. To inactivate endogenous peroxidases, slides were incubated in 
3% hydrogen peroxide in MeOH for 10 min. Then, slides were incubated with Avidin/ Biotin for 
15 min each and after with normal horse serum (HNS) (VECTASTAIN Elite ABC Kit) for 30 min, 
followed by an overnight incubation in diluted primary antibody PECAM-1/CD31 (Santa Cruz) in a 
1:200 dilution. After, slides were incubated with biotinylated horse anti-goat secondary antibody 
(Vector Labs) in a 1:500 dilution in HNS for 1h, and next, peroxidase-labeled reagent for 5 min 
(VECTASTAIN® ABC reagent, Vector Labs). Slides were incubated with 3,3’-diamino-benzidine 
(DAB + Substrate System, DakoCytomation). Finally, slides were counterstained with hematoxylin 
and permanently mounted. All dilutions were made in PBS, pH 7.5, and all incubations were 
performed in humid chambers at room temperature. Between each step in the staining 
procedure (except before incubation with primary antibody), the slides were rinsed twice in PBS. 
In all reactions a negative control was included, where the staining was performed with the same 
protocol above described without primary antibody. 
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2.8. Vessel Density quantification 
 
For evaluation of vessel density, slides were scanned in the light microscope (Olympus 
BX61, Tokyo, Japan) at × 20 magnification at least in 5 different representative fields of the slide. 
Vessel density was determined by counting the number of CD31+ vessels per measurement field 
at × 200 magnification (× 20 lens, × 10 ocular, measurement field of 0.143642mm2) by a 
blinded examiner. A vessel was defined as any distinct CD31+ cell cluster with an area exceeding 
5 µm2. The numbers of vessel counted in the analyzed areas were averaged per number cross 
sections and denoted Vessel Density. The evaluation was performed to the tree groups at E15.5 
(Csf1r+/+: n=6; Csf1r-/+: n=5 and Csf1r-/-: n=3), E18.5 (Csf1r+/+: n=5; Csf1r-/+: n=6 and Csf1r-/-: n=3) 
and P0 stage (Csf1r+/+: n=6; Csf1r-/+: n=5 and Csf1r-/-: n=6). 
 
2.9. RNA extraction and cDNA synthesis 
 
The lungs were dissected and placed immediately in liquid nitrogen and then frozen at -
80ºC until the extraction. Total RNA from lung samples was extracted using TRIzol® 143 
Reagent (Invitrogen, San Diego, CA) with PureLink TM RNA Mini Kit, according to the 
manufacturer’s instructions. The lungs was kept in ice and added 500, 750 or 1000 µl of TRIzol 
to E15.5, E18.5 and P0 lungs, respectively. To disrupt the lung sample was used up-and-down 
movements with a pestle. After lysis, the lysate was homogenized trough an 18 and 25-gauge 
needle attached to an RNase-free syringe. The lysate was incubated at room temperature for 5 
min to allow the complete dissociation of nucleoprotein complexes. Then, it was added 0,2 ml 
chloform per 1ml TRIzol reagent used, shaking the tube vigorously by hand for 15 seconds, 
followed by incubation for 2-3 min at RT. The samples were centrifuged at 12,000 x g for 15 min 
at 4ºC and 400 µl of the colorless, upper phase containing the RNA was transferred to a fresh 
Rnase-free tube, added an equal volume 70% ethanol the tube mixed well, using a vortex.  The 
sample were transferred to a spin cartridge (with a collection tube), centrifuged at 12,000 x g for 
15 sec at RT. The flow-through was discarded and this process was repeated until the entire 
sample was processed. After, the On-column PureLink TM DNase treatment and purification kit 
was used to perform the DNA genomic elimination. Then, 350 µl Wash buffer I was added to the 
spin cartridge containing the bound RNA and centrifuged at 12,000 x g for 15 sec at RT. The 
flow-through was discarded and the spin cartridge inserted into a new collection tube. 80 µl of 
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PureLink TM Dnase mixture was added directly onto the surface of the spin cartridge membrane, 
incubating at RT for 15 min. 350 µl of wash buffer I was added to the spin cartridge and 
centrifuged at 12,000 x g for 15 seconds at RT. The flow-through and collected tube and insert 
the spin cartridge into a new collection tube. 500 µl of Wash buffer II with ethanol was added to 
the spin catridge and centrifuged at 12,000 x g for 15 seconds at RT, discarding the flow-through 
and repeated the wash with wash buffer I and with buffer II. The spin cartridge was centrifuged 
for 1 min to dry the membrane with the bound RNA. Finally, 30-50 µl of Rnase-free water was 
added to the center of the Spin Cartridge and recovery tube and centrifuged for 1 min at RT. The 
concentration and purity were analyzed using a Nanodrop® Spectrometer.  
After total RNA extraction, 1 µg of total RNA/sample was submitted to reverse transcription with 
Maxima-Reverse Transcriptase (Thermo Scientific) for 10 min at 25°C, 15 min at 50°C and 5 
min at 85°C utilizing 50 pmol random hexameric primers/oligo (dT)18 and random hexamer 
primers on the MyCycler™ thermal cycler (Bio-Rad).  
2.10. Quantitative Real-Time PCR (q-PCR) 
 
Relative gene expression of Vegfa, Flk1, Ang1, Ang2, Hif1α e Fgf2 was assessed using 
the Maxima Probe/ROX qPCR Master Mix (2X) (Thermo Scientific). For the following genes with 
sequence ID (enclosed between brackets), commercially available Taqman probes were ordered 
(Applied Biosystems): Vegfa (Mm01281449_m1), Flk1 (Mm01222421_m1), Ang1 
(Mm00456503_m1), Ang2 (Mm00545822_m1), Hif1α (Mm01283760_m1), Fgf2 (Mm 
00433287_m1) Gapdh (Mm99999915_g1).  cDNA expression levels were assessed by 
quantitative real time PCR reaction (2 min 50°C, 5 min 95°C, 40 cycles at 95° C for 15 sec and 
60°C for 1 min) using the CFX96™Real-Time System (Bio-Rad). The housekeeping GAPDH gene 
was used as internal references for normalization and the transcript levels was calculated by 
using a comparative threshold cycle method and the formula 2(−ΔΔCt) (Ct - threshold cycle) [95]. 
 
2.11. Weigert’s staining  
 
To Weigert’s stain, 3 µm slides paraffin-embedded were used. Briefly, paraffin sections 
were deparaffinized and rehydrated. After, incubated 1h 30min with Weigert’s solution (Weigert’s 
58 
 
Resorcin Fuchsin, Sigma-Aldrich), following by tree washes with EtOH 100%, 5min with xylol and 
mounted. 
 
2.12. Arterial thickness evaluation 
 
For evaluation of arterial thickness, slides stained with Weigert’s coloration were scanned 
in the light microscope (Olympus BX61, Tokyo, Japan) at × 40 magnification at least in 5 
different representative fields of the slide. Pulmonary arteries were distinguished from pulmonary 
veins on the basis of the structure. Arteries with clear visible external and internal elastic laminae 
(which comprise tunica intima, media and adventitia) were analyzed and the distance between 
these two points was calculated. The evaluation was performed to the tree genotypes at E18.5 
(Csf1r+/+: n=5; Csf1r-/+: n=5 and Csf1r-/-: n=) and P0 stage (Csf1r+/+: n=6; Csf1r-/+: n=5 and Csf1r-/-: 
n=5). 
2.13. Statistical Analysis  
 
 All experiments were analyzed using Student’s t-test (GraphPad Prism 5). Results are 
expressed as mean ± SEM. Differences were considered statistically significant when p≤0.050. 
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3. RESULTS 
 
3.1. Impact of macrophages deletion in pseudoglandular stage of lung 
development (E15.5) 
 
3.1.1. Lung gross morphology 
 
In order to evaluate if the Csf1r deletion results in a visible disruption in the 
pseudoglandular developmental stage (E15.5) of murine lungs, the gross morphology was 
analyzed. The correspondent pictures are represented above (figure 10). The knockouts mutant 
embryos, Csf1r+/- (n=9) and Csf1r-/- (n=4), didn’t show gross lung developmental abnormalities 
when compared with control (n=8). Also no gross differences in size and aspect were found, 
between the different genotypes. 
 
Figure 10. Gross morphology evaluation of lung embryos at E15.5 stage. Above are represented the 
illustrative lung pictures immediately after dissection at E15.5 stage. No differences in size, shape and gross 
morphology were found between Csf1r+/- and Csf1r-/- and wild type lungs. Magnification: 1.6x. 
  
3.1.2 Lung bud number  
 
Macrophages are present since early steps of lung development, and closely associated 
with mesenchyme and with elongating lung buds [88]. In other branching systems, such as 
kidney, mammary gland and pancreas, macrophages reside in abundant number, providing a 
strong regulation on organ branching [24]. Therefore, the branching program of lung 
development could be affect by macrophage ablation. In this way, we evaluated, by gross 
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dissection at E15.5, if the lungs from knockout mice (Csf1r+/- and Csf1r-/-) showed an alteration on 
lung bud number (figure 11). Indeed, these animals didn’t seem to have alteration on 
branching structures number. In order to check this fact, the number of left lung lobe buds at 
E15.5 stage was quantified and the results are represented in the figure 12.  
 
 
 
 
 
 
 
The Csf1r+/- and Csf1r-/- animals showed a slight decrease in the number of buds, median 
of 30.07 (n=6) and 30.05 (n=4) respectively, when compared with control group, median of 32 
buds (n=2). No statistical significance was found between Csf1r+/+ and Csf1r+/- animals (p= 0.729), 
Csf1r+/+ and Csf1r-/- (p=0.788), Csf1r+/- and Csf1r-/- (p=0.949). These results didn’t suggest 
alteration in the branching process for both Csf1r knockouts (Csf1r+/- and Csf1r-/-). 
 
 
Figure 12. Number of buds in left lung lobe at E15.5 stage. Above are represented the number of buds of 
left lung lobe of Csf1r+/+, Csf1r+/- and Csf1r-/- animals. Both knockout animals, Csf1r+/- and Csf1r-/-, show a small 
decrease in the number of buds of left lobe, without statistical differences. Lungs analyzed: n= 2 of Csf1r+/+; n=6 of 
Csf1r+/-; n=4 of Csf1r-/. Data is represented as mean ± SEM. 
Figure 11. Representative pictures of left lung lobe at E15.5. Above are exemplified the representative left 
lung lobe pictures immediately after dissection at E15.5 stage. As can be seen the number of buds not appear to be 
altered in the different genotypes.  Arrows indicate bud structures. Magnification: 1.6x. 
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3.1.3. Lung morphology  
 
In order to characterize the progression of lung formation in the macrophage deficient 
embryos (Csf1r+/- and Csf1r-/-) compared with wild-type (Csf1r+/+), the lung morphology was 
evaluated by stereological analysis of hematoxylin–stained sections.  The histological pictures of 
lung morphogenesis at E15.5 stage are showed below in figure 13. No apparent differences in 
lung morphogenesis were observed in wild-type versus Csf1r+/- embryos. However, when 
compared the wild type versus Csf1r-/- lung embryos, an increase in mesenchymal and a slight 
decrease in epithelial and airspace components was observed. 
 
 
Figure 13. Lung embryos histological sections at E15.5 stage. Representative pictures of lung histology at 
E15.5 of Csf1r+/+, Csf1r+/- and Csf1r-/- animals. An increase in mesenchymal and a decrease in epithelial tissue is 
observed when compared Csf1r-/- with wild type animals. Magnification: top panel 10 x, bottom panel 20x. 
 
The histologic differences between the different genotype animals were examined in 
detail, quantifying lung histological structures. Using stereological analyses, the mesenchymal, 
epithelial and airspace volume density (VD) were determined to Csf1r+/+, Csf1r+/- and Csf1r-/- 
(figure 14). Morphometric measurements showed that mesenchymal VD of Csf1r-/- lung 
embryos presented a 20% increase (67.07±2.22%) compared with wild type embryos (55,96 
±5.45%). However, no statistically differences were found, (p=0.153). The Csf1r+/- group didn’t 
shows remarkable difference (55.56±1.75%) compared with wild type group (p=0.953), but with 
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significant differences when compared with Csf1r-/- group (p=0.007). Regarding epithelial VD, 
Csf1r-/- embryos didn’t shows significant differences (12.69±0.45%) compared with wild type 
(13.32±1.40%; p=0.681). Csf1r+/- embryos showed lower values of epithelial VD (10.76±0.43) 
compared with control (p=0.130) and with Csf1r-/- group (p=0.020). At last, regarding airspace 
VD, Csf1r-/- lung embryos showed a mean of 3.28±0.28%, Csf1r+/- of 2.60±0.43% and wild type 
embryos of 3.66±0.37%. No statistical differences were found when compared Csf1r-/- and Csf1r+/- 
with wild type embryos (p=0.473 and p=0.127, respectively) or with Csf1r+/- (p=0.218). 
 
 
Figure 14. Lung stereological analyses at E15.5 stage. Above are represented the stereological results   of 
mesenchymal, epithelial and air space volume density (VD). Animals analyzed: n=5 Csf1r+/-, n= 4 Csf1r-/-, n=4 
Csf1r+/+. The mesenchymal VD was higher in Csf1r-/- lungs when compared with wild type, while epithelial and air 
space VD were slight decrease. Data is represented as mean ± SEM. *p<0.050;**p<0.010. 
 
1.1.4. Lung vasculature   
 
There is a strong structural and functional association between lung branching and vascular 
development. The disruption of endothelial cell development is accompanied by an inhibition of 
airway epithelial cell differentiation and maturation [96]. More, during organ development and 
remodeling, macrophages support angiogenesis, not only by the expression of proangiogenic 
factors and matrix-remodeling proteases, but also by the physical interaction with vessels [97]. 
Thus, we hypothesize that macrophage ablation, trough the Csf1r deletion, may impact lung 
vascular development. In this way, we assess the lung vessel density using a specific endothelial 
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cell marker, CD31. At E15.5 stage an apparent increase in the number of CD31 positive vessels 
were observed in Csf1r+/- and Csf1r-/- compared with wild type (figure 15). 
 
Figure 15. CD31 immunohistochemical staining in lung embryos at E15.5. The CD31 endothelial cell 
marker was used to stain blood vessels specific cells, endothelial cells (black arrows). An increase in the number of 
vessels for knockout animals was found at E15.5 stage. Magnification: 20x. 
  
 In order to evaluate if the previous subjective analysis of vessel number corresponds to 
statistical difference in the number of vessels, the vessel density was calculated for the different 
genotypes. The vessel density was determined by counting CD31 positive vascular structures per 
lung sections and the results are in figure 16. Csf1r+/- showed a vessel median of 4.10±0.38, 
Csf1r-/- of 4.08±0.55 and wild type of 3.37±0.47. Therefore, knockout animals presented a minor 
increase in the vessel density compared with control. However, no statistical differences were 
found (Csf1r+/- vs wild type p=0.269, Csf1r-/- vs wild type p=0.386, and Csf1r+/- vs Csf1r-/- 
p=0.980). 
 
 
Figure 16. Vessel density in lung embryos at E 15.5 stage. Vessel density was determined by counting 
CD31 positive vascular structures. Knockout animals (Csf1r+/- and Csf1r-/-) showed a minor increase in the number of 
blood vessels. n= 6 of Csf1r+/+; n=5 of Csf1r+/- and n=3 of Csf1r-/- lungs were analyzed. Data is represented as mean ± 
SEM.  
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3.1.5. Gene expression of angiogenic factors  
 
The vasculature is a result of a balance of pro and anti-angiogenic factors, which drives 
the orchestration of vascular network. In this way, the evaluation of gene expression of key 
angiogenic factors during lung development will allow to identify whether the balance is affected 
and which factors could be involved. Therefore, in this study, we have performed an RNA levels 
quantification of some angiogenic factors:  VEGF-A, Flk-1, Ang-1, Ang-2, HIF-1a and Fgf2 (figure 
17). 
 At E15.5 stage, the vascular endothelial growth factor A (VEGF-A) transcripts of Csf1r+/- 
lungs showed median folds increase of 1.13±0.087 and, Csf1r-/- of 1.16±0.011 relative to wild 
type (1.00±0.041). However, these differences weren’t statistically significant (Csf1r+/- vs wild 
type p=0.206; Csf1r-/- vs wild type p=0.126; Csf1r+/- vs Csf1r-/- p=0.826).  This trend was also 
observed in the transcripts levels of VEGF-A receptor, Flk-1 (VEGR-2). Csf1r+/- showed median fold 
changes of 1.47±0.117, Csf1r-/- of 1.30±0.135 and wild type of 1.00±0.052. Csf1r+/- and Csf1r-/- 
Flk-1 transcripts were significantly increased comparing with wild type (p=0.003 and p=0.018, 
respectively). Concerning, angiopoietin-1 (Ang-1) expression levels, Csf1r+/- and Csf1r-/- showed no 
fold changes comparing with wild type (medians to Csf1r+/- 1.06±0.049, Csf1r-/- 1.06±0.076 and 
wild-type 1.00±0.046). Therefore, no statistical differences were found (Csf1r+/- vs wild type 
p=0.381, Csf1r-/- vs wild type p=0.941, Csf1r+/- vs Csf1r-/- p=0.541). On the other hand, the gene 
expression levels of angiopoietin-2 (Ang-2) were 1.53±0.075 fold increase in Csf1r+/- and 
1.47±0.143 in Csf1r-/- comparing with wild-type (1.00±0.074), being these differences statistically 
significant (p=0.0002 and  p=0.008, respectively).  
Concerning hypoxia inducible factor 1 alpha (HIF-1a) transcripts levels, no statistical 
differences were found in the mean fold changes of Csf1r+/- (1.00±0.066, 0.975) and Csf1r-/- 
(0.98±0.101, 0.885) compared with wild type (1.00±0.078). 
 At last, Fgf2 gene expression levels were significant 2.55±0.147 fold higher in Csf1r-/- 
(p=0.003). Regarding Csf1r+/-, significant differences were observed comparing with wild type 
(p=0.006), but no with Csf1r-/- (p=0.257). 
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Figure 17. Angiogenic factors gene expression profile by qPCR of lungs at E 15.5. Comparison of VEGF-
A, Flk-1, Ang-1, Ang-2, HIF-1a and Fgf2 gene expression of Csf1r+/- and Csf1r-/- with Csf1r+/+animals. All genes were 
normalized against GADPH expression. Lungs analyzed: n= 8 of Csf1r+/+; n=9 of Csf1r+/-; n=6 of Csf1r-/-. 
*p<0.050;**p<0.010 
 
 
3.2. Impact of macrophages deletion in fetal saccular stage of lung 
development (E18.5)  
 
3.2.1. Lung gross morphology 
 
At fetal saccular stage, E18.5, gross morphology observation of Csf1r-/- lungs (n=2) 
indicated a reduced size when compared with Csf1r+/- (n=4) and wild type lungs (n=6). This 
difference was particularly pronounced in the left and accessory lobe. However, the shape and 
lung structure remains unaltered. At this stage, the heterozygotes lungs (Csf1r+/-) didn´t appear 
different in the shape and size when compared with wild type (figure 18). 
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3.2.2. Lung morphology  
 
The lung histology at E18.5 stage is showed below in figure 19. No apparent 
differences in lung morphogenesis were observed in wild type versus Csf1r+/- embryos. However, 
when comparing wild type versus Csf1r-/- lung embryos an increase in mesenchymal and a 
reduction in area space tissue were observed. Also, reduction of primitive pre-alveoli (black 
arrows) in Csf1r-/- were founded compared to wild type lung embryos. These histological analyze 
showed that the morphogenesis of Csf1r-/- lungs appeared to be delayed at more early stage of 
development. 
 
Figure 19. Lung embryos histology at E18.5 stage. Representative pictures of lung histology at E18.5 of 
Csf1r+/+, Csf1r+/- and Csf1r-/- animals. A decrease in epithelial tissue is observed when compared Csf1r+/- and Csf1r-/- 
with wild type embryos, as well as a reduction of primitive pre-alveoli (black arrows). The Csf1r-/- animals showed also 
an increase in mesenchymal tissue compared with wild type group. Magnification: top panel 10 x, bottom panel 20x. 
Figure 18. Gross morphology evaluation of lung embryos at E18.5 stage. Above are represented the 
illustrative lung pictures immediately after dissection at E18.5 stage. At this stage, the Csf1r+/- lungs didn’t show 
apparent difference when compared with Csf1r+/+. However, the Csf1r-/- embryos showed smaller lung lobes when 
compared with wild type and Csf1r+/- lungs. Magnification: 0.8x. 
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In order to quantify these observations, stereological analyses were performed. 
Morphometric measurements (figure 20) showed that mesenchymal VD of Csf1r-/- lung embryos 
were significantly higher (14.66±1.17%) compared with wild type (10.01 ±0.10%), (p=0.023). 
The Csf1r+/- group didn’t show remarkable difference (9.25±1.01%) compared with wild type 
group (p=0.613). When compared with Csf1r-/- embryos a statistically difference was founded 
(p=0.036). Regarding epithelial VD, Csf1r-/- and Csf1r+/- embryos showed a significant decrease 
(42.55±0.87% and 39.19±1.74%, respectively) compared with wild type (51.45±0.92%) 
(p=0.003 and p=0.001, respectively). At last, concerning airspace VD Csf1r-/- lung embryos 
presented a mean of 16.17±1.343%, Csf1r+/- of 21.60±2.69% and wild type embryos of 
18.11±0.91%. Although a slight increase was observed comparing Csf1r+/- and Csf1r-/- with wild 
type, no statistical differences were found (p=0.264 and p=0.582, respectively). 
 
 
Figure 20. Lung embryos histology at E18.5 stage. Representative pictures of lung histology at E18.5 of 
Csf1r+/+, Csf1r+/- and Csf1r-/- animals. A decrease in epithelial tissue is observed when compared Csf1r+/- and Csf1r-/- 
with wild type embryos. The Csf1r-/- animals shows also an increase in mesenchymal tissue compared with wild type 
group. 
 
3.2.3. Lung vasculature  
 
We assessed the vessel density at E18.5 stage in order to understand if lung vasculature 
was affected by macrophage deletion and an apparent decrease in the number of CD31 positive 
vessels was observed in Csf1r+/- and Csf1r-/- compared with wild type (figure 21). 
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Figure 21. CD31 immunohistochemical staining in lung embryos at E18.5. The CD31 endothelial cell 
marker was used to stain blood vessels specific cells, endothelial cells (black arrows). A decrease in the number of 
vessels for knockout animals was found at this stage. Magnification: 20x. 
 
In order to evaluate if the previous vessel structure observations resembled a real impact 
in the number of vessels, the vessel density was calculated for the different genotypes. The 
vessel density was determined by counting CD31 positive vascular structures and the results are 
below (figure 22). At E18.5 stage, Csf1r+/- shows a median vessel density of 2.64±0.19, Csf1r-/- 
of 2.52±0.25 and wild type of 3.29±0.36. Therefore, knockout animals shows a decrease in the 
number of vessels compared with control, however without statistically significant differences 
(Csf1r+/- vs wild type p=0.132, and Csf1r-/- vs wild type p=0.188). 
 
 
Figure 22. Vessel Density quantification at E 18.5. Vessel density was determined by counting CD31 positive 
vascular structures. Knockout animals (Csf1r+/- and Csf1r-/-) showed a decrease in the number of vascular structures. 
n= 5 of Csf1r+/+; n=6 of Csf1r+/- and n=3 of Csf1r-/- lung animals were analyzed. Data is represented as mean ± SEM. 
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3.2.4. Gene expression of angiogenic factors  
 
We performed a transcripts levels quantification of the following angiogenic factors: VEGF-
A, Flk-1, Ang-1, Ang-2, HIF-1a and Fgf2, at E18.5 stage (figure 23). 
Regarding VEGF-A expression fold change Csf1r+/- and Csf1r-/- lungs presented 
0.67±0.067 and 0.65±0.086, respectively, compared with wild type (1.00±0.055), with 
statistically significant differences (p=0.002 and p=0.005), respectively. 
 Flk-1, also showed this trend, with Csf1r+/- showing a median fold decrease of 
0.93±0.074, Csf1r-/- of 0.86±0.080 comparing the control (1.00±0.060). However, no statistical 
differences were obtained (p values>0.050). Ang-1 expression levels were similar in knockout 
(Csf1r+/- of 1.00±0.056 and Csf1r-/- of 1.09±0.064) compared with wild type lungs (1.00±0.039), 
with no statistical differences (p values>0.050). 
 To Ang-2, the median fold change of Csf1r+/- was 0.89±0.027, Csf1r-/- 0.78±0.060 having 
wild type as reference (1.00±0.047). Therefore, a significant decrease in the expression of Ang-2 
was found for Csf1r-/- animals comparing with wild type (p=0.025), but not for Csf1r+/- (p=0.119). 
Regarding, HIF-1 the fold change of Csf1r+/- (0.97±0.044), Csf1r-/- (1.05±0.058) and 
wild-type (1.00±0.033) was similar. Therefore, no differences were found in the gene expression 
levels (p>0.400). At last, Fgf2 gene expression levels didn’t show statistical differences 
(p>0.400); with the median fold change of Csf1r+/- of 1.023±0.065, Csf1r-/- of 1.045±0.066 and 
wild type of 1.00±0.025.  
 
 
Figure 23. Angiogenic factors gene expression profile by qPCR of lung at E 18.5. Comparison of VEGF-
A, Flk-1, Ang-1, Ang-2, HIF-1a and Fgf2 gene expression between Csf1r+/- and Csf1r-/- with Csf1r+/+animals. All genes 
were normalized against GADPH expression. Lungs analyzed: n= 10 of Csf1r+/+; n=7 of Csf1r+/-; n=4 of Csf1r-/. 
*p<0.050;**p<0.010 
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3.2.5. Arterial thickness  
 
The previous results suggest that the macrophage-deficient-mice present a deficient vasculature. 
Thus, we performed complementary evaluation specifically about the arteries structures. The 
comparison between the artery thicknesses between the different genotypes trough the 
representative pictures didn’t evidence differences (figure 24). In order to check this apparent 
similar thickness, the measurement of the arteries thickness was performed (figure 25). The 
artery thickness was determined by the measurement of distance between external and internal 
elastic fibers. The Csf1r+/- animals showed a median of artery thickness of 2.571± 0.220, Csf1r-/- 
of 2.808±0.318 and wild type of 2.789± 0.220. The results didn’t showed significant differences 
(Csf1r+/- vs wild type p=0.492, Csf1r-/- vs wild type p=0.959, between knockouts p=0.550).  
 
 
 
 
 
 
 
 
 
 
 
 
Figure 25. Arterial thickness evaluation at E18.5 stage. Comparison between the artery thickness of 
Csf1r+/+, Csf1r+/- and Csf1r-/- animals. The results didn’t shows remarkable differences between the three genotypes. 
Data is represented as mean ± SEM. 
Figure 24. Arterial thickness at E18.5 stage. Comparison between Csf1r+/+, Csf1r+/- and Csf1r-/- animals. The 
results didn’t shows remarkable differences between the three genotypes. Arrows point the elastic fibers in purple 
that highlight the characteristic structure of these blood vessels: the tunica intima (more internal elastic lamina), the 
tunica media (between the two elastic laminas) and the tunica adventitia (blending in with lung airways). 
Magnification: 40 xs. 
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3.3. Impact of macrophages deletion in post-natal saccular stage of 
lung development (P0)  
 
3.3.1. Lung gross morphology 
 
In order to evaluate if macrophages deletion results in a visible disruption in the 
development of post-natal murine lungs, the gross morphology was analyzed after birth (P0). The 
correspondent pictures are represented above (figure 26). The knockouts mutant embryos, 
Csf1r+/- and Csf1r-/-, didn’t showed gross differences in size and aspect when compared with wild 
type. 
 
Figure 26. Gross morphology evaluation of lung newborns at P0 stage. Above are represented the 
illustrative lung pictures immediately after dissection at P0 stage. No gross differences in size, shape and 
morphology were found between Csf1r+/- and Csf1r-/- and wild type lungs. Magnification: 0.7x. 
 
3.3.2. Lung-to-body weight ratios  
 
In order to understand if macrophage deletion results in lung hypoplasia, the left, right 
and total lung-to-body weight ratio were calculated for the different genotypes (figure 27). The 
results didn’t shows remarkable differences between the knockouts and wild type animals. For 
left lung-to-body ratio the Csf1r+/- animals showed a median of 0.0081± 0.0005, Csf1r-/- of 
0.0102±0.0009 and wild type 0.0089± 0.0010, with no statistical differences (Csf1r+/- vs wild 
type p=0.404, Csf1r-/- vs wild type p=0.406, between knockouts p=0.043). For the right lung-to-
body ratio, Csf1r+/- animals showed a mean of 0.0161± 0.0005, the Csf1r-/- 0.0197±0.0019 and 
wild type 0.0174± 0.0008, with statistical differences only between the knockouts animals 
(p=0.024). For the total lung-to-body ratio, similar tendencies were observed, with the knockout 
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lungs presenting a significant difference (p=0.015) (mean: Csf1r+/- 0.0242±0.0008, Csf1r-/- 
0.0299±0.0026 and wild type 0.0263± 0.0016).  
 
 
Figure 27. Left, right and total lung-to-body weight ratio at P0 stage. Comparison of left, right and total 
lung by all body weight between Csf1r+/+, Csf1r+/- and Csf1r-/- animals. The results didn’t show differences between the 
knockout and wild type mice. *p <0.050 
 
3.3. Neonatal blood gasometry  
 
In order to understand if the alterations on vascular component results in an impairment 
of respiratory capacity, it was performed blood gasometric evaluation immediately after birth. The 
blood was collected after decapitation and gasometric evaluation of pH, partial pressure of CO2, 
O2 (PCO2 and PO2 respectively), as well saturation of O2 (Sat O2) and Lactate concentration (Lac) 
was performed. Concerning pH, no differences were found between the tree genotypes 
(p>0.100).  
When compared with control, knockout neonates presented a slight increase in PCO2 and PO2, 
with no statistical differences (p>0.050). Regarding SatO2, again no differences were found 
between the tree genotypes (p>0.200). Lastly, when compared with control, Csf1r-/- neonates 
presented an increase in lactate values. However, no statistical difference was observed 
(p>0.050).     
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Table 1. Neonatal blood gasometric evaluation after birth 
 
 pH PCO2 (mmHg) 
 
PO2 (mmHg) 
 
SatO2 (%) Lac (mmol/L) 
Csf1r+/+ 7.64±0.03 28.30±3.15 48.00±5.86 89.33±5.17 2.36±0.55 
Csf1r+/- 7.51±0.06 39.98±4.11 62.40±12.26 88.20±5.84 1.57±0.49 
Csf1r-/- 7.58±0.02 37.40±1.30 62.00±13.00 93.00±4.00 3.23±1.33 
P- partial pressure; Sat- saturation. Values represent the mean ±SEM of measurements. 
 
3.3.4. Lung morphology  
 
The histological pictures of lung morphogenesis at P0 stage are showed below in figure 
28. No apparent differences in lung morphogenesis were observed in wild type versus Csf1r+/- 
newborn. However, when compared the wild type versus Csf1r-/- animals, the knockout lungs 
were severely hypoplastic with greatly increased mesenchymal cellularity and reduced epithelial 
tissue. Also, pre-alveoli were greatly reduced when compared with wild type embryos, which 
presented a defined network of air change. Additionally, the air space was reduced in Csf1r-/- lung 
embryos. Indeed, the morphogenesis of Csf1r-/- lungs appeared to be delayed at more early stage 
of development. 
 
 
Figure 28. Lung histology at P0 stage. Representative pictures of lung histology of Csf1r+/+, Csf1r+/- and Csf1r-/- 
animals at P0 stage. Reduced air space and increased cellularity in Csf1r-/- animals compared either with Csf1r+/- and 
the control is clearly visible. These animals showed an increase in mesenchymal tissue, a decrease in air space and 
epithelial area. Magnification: top panel 10 x, bottom panel 20x. 
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Next, to determine the extension of these observations in mutant animals (Csf1r-/-), 
stereological analyze was performed. At P0 stage, beyond the morphometric measurements of 
mesenchymal and air space VD, it was also calculated the small (epithelial and septum) and 
large (bronchiolar) epithelium (figure 29). The quantification results showed that large 
epithelium VD of Csf1r-/- lung was significantly reduced (0.21±0.02%) compared with wild type 
newborns (1.33±0.16%) (p=0.002). Regarding small epithelium VD, Csf1r-/- newborns showed a 
minor increase (28.56±5.42%) compared with wild type (22.53±1.62%) (p=0.327). Concerning 
mesenchymal VD, Csf1r-/- lung newborns showed a mean of 9.49±2.21%, Csf1r+/- of 1.12±0.49% 
and wild type of 1.34±0.88%. A great increase was found in Csf1r-/- comparing with wild type 
(p=0.014) and comparing with Csf1+-/- (p= 0.004). Between Csf1+-/- and wild type no remarkable 
differences were found (p=0.820). Finally, regarding air space, Csf1r-/- lung newborns showed 
mean of 31.45±2.73%, Csf1r+/- 45.97±2.09% and wild type (53.24±4.95%). Therefore, a 
significant decrease in Csf1r-/- animals was found (p=0.008). 
 
Figure 29. Sterelogical analyses at P0 developmental stage. Above are represented the stereological results 
of mesenchymal, epithelial (large and small airways) and air space volume density.  n=4 for Csf1r+/+-, n= 5 Csf1r+/- 
and n=4 for Csf1r-/- group. The large epithelium showed a decrease in Csf1r-/- animals. The mesenchymal VD was 
higher in Csf1r-/- lungs when compared with wild type. The air space VD was lesser in knockout animals. Data is 
represented as mean ± SEM. *p<0.050**p<0.010 
 
3.3.5. Lung vasculature  
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We assessed lung vessel structure at P0 stage in order to understand if vessel number 
was affected.  An apparent decrease in the number of CD31 positive vessels were found in 
Csf1r+/- and Csf1r-/- compared with control (figure 30). 
 
 
 
Figure 30. CD31 immunohistochemical staining in lung embryos at P0 stage. The CD31 endothelial cell 
marker was used to stain blood vessels specific cells, endothelial cells (black arrows). A decrease in the number of 
vessels for knockout animals was observed. Magnification: 20x. 
 
In order to evaluate if the previous subjective analysis of vessel constitution corresponded 
to a real impact in the number of vessels; the vessel density was calculated for the different 
groups. The vessel density was determined by counting CD31 positive vascular structures and 
the results are below (figure 31). At P0 stage, Csf1r+/- showed a median of 2.54±26, Csf1r-/- of 
2.22±0.15 and wild type of 3.76±0.32. Therefore, knockout animals exhibited almost a two-fold 
decrease in vessel density compared with wild type (Csf1r+/- vs wild type p=0.016 and Csf1r-/- vs 
wild type p=0.002). 
 
3.3.6. Gene expression of angiogenic factors  
 
We performed a quantification of transcript levels of relevant angiogenic factors (VEGF-A, 
Flk-1, Ang-1, Ang-2, HIF-1a and Fgf2) (figure 32).  
At P0 stage, Csf1r+/- lungs showed median VEGF-A expression fold changes of 
1.81±0.125, Csf1r-/- of 1.68±0.223 with wild type as reference (1.00±0.160). Therefore, both 
knockout animals showed a significant increase in the expression levels of VEGF-A (Csf1r+/- vs wild 
type p=0.001 and Csf1r-/- vs wild type p=0.033).  In VEGR-2, this trend was also observed, with a 
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median fold change of Csf1r+/- 1.59±0.116, Csf1r-/- 1.58±0.193 and wild-type 1.00±0.107. 
Therefore, gene expression levels of Flk-1 were 59 and 58% higher in Csf1r+/- (p=0.002) and 
Csf1r-/- (p=0.016), respectively, comparing with wild type. Concerning Ang-1, Csf1r+/- shows a 
median fold change of 5.52±0.918, Csf1r-/- of 5.03±1.993 and wild type of 1.00±0.192. 
Therefore, knockout animals presented a significant high increase in Ang-1 transcript levels 
(Csf1r+/- vs wild type p=0.001 and Csf1r-/- vs wild type p=0.012. On the other hand, only Csf1r-/- 
showed fold increase in Ang-2 expression (2.16±0.412 vs 1.10±0.080 in Csf1r+/- and 1.00±0.088 
in wild-type), with statistical differences (p=0.001). Concerning HIF-1a, a median fold change of 
1.06±0.039 in Csf1r+/-, 1.25±0.154 in Csf1r-/- was observed. No statistical differences were found 
(p>0.050). Additionally, no statistical differences were observed in Fgf2 change expression levels 
(p>0.050), with Csf1r+/- presenting a median of 1.10±0.065, Csf1r-/- of 1.09±0.105 and wild type 
of 1.00±0.180.  
 
 
Figure 31. Angiogenic factors gene expression profile by qPCR of lung newborns at P0. Comparison of 
VEGF-A, Flk-1, Ang-1, Ang-2, HIF-1a and Fgf2 gene expression between Csf1r+/- and Csf1r-/- with Csf1r+/+ animals.. All 
genes were normalized against GADPH expression. . Lungs analyzed: n= 9 of Csf1r+/+; n=13 of Csf1r+/-; n=2 of Csf1r-/-. 
*p<0.050;**p<0.010 
 
3.3.7. Arterial thickness  
 
The previous results suggest that the macrophage-deficient-mice can show pulmonary 
hypertension, since the up regulation of VEGF-Flk1 pathway is verified. In this pathology the 
increase in artery thickness is a characteristic point [98]. Therefore, the alteration of artery 
thickness could be used as an indirect pulmonary hypertension assessment. The comparison 
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between the artery thicknesses between the genotypes trough the representative pictures didn’t 
showed differences (figure 33). In order to check this apparent similar thickness, the 
measurement of the arteries thickness was performed (figure 34). The results didn’t showed 
considerable differences. The Csf1r+/- animals showed a mean of 2.727±0.195, Csf1r-/- of 
2.627±0.209 and wild type of 2.377±0.219 (p>0.050).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 33. Arterial thickness evaluation at P0 stage.  Comparison between the artery thickness of Csf1r+/+, 
Csf1r+/- and Csf1r-/- animals. The results didn’t shows remarkable differences between the three genotypes. Data is 
represented as mean ± SEM. 
 
 
 
 
Figure 32. Arterial thickness at P0 stage. Comparison between Csf1r+/+, Csf1r+/- and Csf1r-/- animals. The 
results didn’t shows remarkable differences between the three genotypes. . Arrows point the elastic fibers in purple 
that highlight the characteristic structure of these blood vessels: the tunica intima (more internal elastic lamina), the 
tunica media (between the two elastic laminas) and the tunica adventitia (blending in with lung airways). 
Magnification: 40 xs. 
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4. DISCUSSION 
 
Nowadays it becomes increasingly clear that macrophages have a higher heterogeneity 
of functions, which are beyond immune context. Their close association with the development in 
organs such as brain [73], pancreas [81], mammary gland [55], kidney [99], among others has 
already been demonstrated. Moreover, some studies have demonstrated the regulation of 
developmental morphogenesis by macrophages, as in vascular system formation and branching 
morphogenesis [24]. Lung is a branching organ and its morphogenesis is dependent on 
interactions between epithelial and endothelial compartments. In fetal lung, macrophages are 
present in mesenchyme throughout all developmental stages, representing around 5% of the total 
lung cells at E15.5 stage and their number increase significantly during post-natal period [31]. 
However, their function and the consequences of macrophage ablation during lung development 
remain unknown. 
The present work characterizes, for the first time, the effect of macrophage ablation in 
the mice lung development process, using a macrophage-deficient mice model, Csf1r-/-. Since the 
disruption of the Csf1r gene results in large depletion of macrophages in most of tissues, it is a 
good model to study trophic roles played by these cells in the development of organ and systems 
[31]. The lung morphology evaluation was accessed by the measurement of histological 
compartments, through stereological analyses. Considering that macrophages have already been 
linked to the angiogenesis in other organs and the crucial relevance of vascular process in lung, 
the present work also addresses the relevance of this population in the regulation of lung 
vasculature, through evaluation of vessel density and of angiogenic factors expression levels. 
Having in mind that macrophage ablation can disrupt lung development, as logical approach, we 
studied the morphology of knockout (Csf1r+/-and Csf1r-/-) per comparison with wild type animals.  
Concerning gross morphology results, the knockout animals didn’t show gross development 
abnormalities comparing with control. Also newborn knockout mice didn’t showed alterations on 
left, right and total lung-to-body weight ratio, which are indicators of pulmonary hypoplasia.   
Nevertheless, the close association of macrophages and the branching process in organs such as 
kidney [99], mammary gland [55] and pancreas [81] led us to investigate if the branching 
process was affected in knockout animals at E15.5 stage. The results didn’t shows significant 
alterations on peripheral airway buds number for both knockout animals comparing with wild 
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type group. However, the number of wild type animals analyzed (n=2) didn’t allow establishing a 
definitive conclusion, being necessary to increase the number of animals analyzed.  
 Regarding histological evaluation, the Csf1r-/- lungs at pseudoglandular stage showed an 
increase in mesenchymal tissue comparing with wild type and Csf1r+/-. This fact points out to an 
impairment of lung development due to macrophages ablation, since the arrest on lung 
development is characterized by an increase in mesenchyme tissue [100]. Furthermore, 
epithelial and air space compartments seems also to be impaired, although without significant 
differences. At fetal saccular stage, beyond the increase in the mesenchyme, a significant 
reduction in epithelial component was observed in Csf1r -/- animals. This finding reinforces the 
question addressed in this work: a deficiency in lung development, namely delay in tissue 
differentiation, due to lack of tissue macrophages. At post-natal saccular stage, again the 
mesenchymal component was increased. The opposite tendency was displayed in large airways 
(bronchiolar) epithelium, with Csf1r-/- presenting a significantly decreased in comparison with wild 
type animals. Moreover, the same trend was found to airspace. These findings indicate that 
tissue macrophages are an important cellular component in the lung morphogenesis, through 
different lung developmental stages, and their ablation is sufficient to cause a delay in lung 
development.  However, it remains to establish which main drivers determine this impairment. 
It’s known that lung morphogenesis depends on epithelial-mesenchymal interactions that are 
governed by numerous growth and transcription factors regulating cell proliferation, differentiation 
and death [101]. Moreover, macrophages are important players in all referred process [101]. 
Moreover, macrophages are important players in all referred process [102]. In lung these events 
are coordinated by a large number of signaling molecules, such as bone morphogenetic proteins 
(BMP), fibroblast growth factors (FGF), Wnt/β-catenin, among others [101]. All described factors 
could constitute important targets to be evaluated, allowing to explain the delay found in the 
development of macrophage-deficient mice. On the other hand, it is known, that structural 
maturation facilitates the progressive gain in gas exchange efficiency [103], what means that this 
delay of lung development could result in impairment on lung function. In this way, the lung 
functionality constituted a rational target to be assessed by gasometry evaluation. 
The gasometry results showed that, while pH values were relatively stable, the partial pressure of 
the carbon dioxide (PO2) was increased in knockout animals.  Normally, the combination of 
lowered pH values and increased PCO2 levels are indicators of respiratory acidosis consistent with 
respiratory function alteration [104]. Therefore, the increase in PCO2 reveals a possible alteration 
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in respiratory (capacity respiration disorders and with lowered ventilation). Regarding pH, this is 
determined by a reason between hydrogen carbonate (HCO3) and CO2 and the increase of partial 
pressure of CO2 results in an increase in [H+] leading to an increase of pH [105]. An increase in 
PCO2 was showed in knockout animals but these animals didn’t showed changes in pH, as would 
be expected. This could be explained by compensatory mechanisms occurring to balance this 
parameter. In agreement with data from the literature, when an acid-base disturbance develops, 
the modulation of various body buffer pairs allows the maintenance of pH levels. For instance, 
phosphate, hemoglobin, and other proteins, including albumin, change in protonated and 
unprotonated concentrations. The organism will then try to correct the extracellular pH towards 
normal [106]. Oxygen deficiency in the organism favours the anaerobic metabolism increasing 
the lactic acid production and decrease of blood’s pH production [107] which didn’t occurred in 
macrophage-deficient mice. The increase of lactate production is associated with oxygen 
deficiency, but the levels of oxygen are similar for all genotypes [107]. The preliminary results 
didn’t showed significant alterations of pH, PO2, PCO2, SatO2 and lactate levels in macrophage-
deficient mice. Nevertheless, the level of PCO2 increases (almost significant value) in these 
animals, which can suggests a possible impact in lung function, since the increase of this 
parameter is a strong indicator of lung inefficient function. However, the number of knockout 
animals analysed was smaller, being necessary to increase it to allow establish definitive 
conclusions.   
Our second goal was to understand whether tissue macrophage ablation impairs 
vascular lung development. It has been demonstrated that during organ development and 
remodelling, macrophages support angiogenesis, not only by the expression of proangiogenic 
factors and matrix-remodelling proteases, but also by the physical interaction with vessels [108]. 
Also, one close link between endothelial and epithelial component drives the lung development. 
Particularly, inhibition of lung endothelial cell development is accompanied by inhibition of airway 
epithelial cell differentiation and maturation [13]. Thus, we hypothesize that macrophage 
ablation, trough the Csf1r deletion, may disrupt lung vascular development, compromising the 
lung development. Our results showed a significant decrease in the vessel number of 
macrophage deficient-mice lungs at post-natal saccular stage. This clear impairment in 
endothelial structure can be associated with morphological alterations described above in 
epithelial/mesenchymal compartments., the interaction between endothelial and 
epithelial/mesenchymal compartments is crucial in lung morphogenesis [109]. Lung vascular 
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orchestration is governed at early stages for angiogenesis and vasculogenesis processes. 
Specifically, the coordination of pro- and anti- angiogenic signals is required for the normal 
development of vascular network in different organs [14]. A large number of molecules are 
known as regulators of angiogenesis. However, it is assumed that the signaling cascade involving 
vascular endothelium factor (VEGF) is the critical pathway in this process since, this growth factor 
is a powerful inducer of angiogenesis in a large number of experimental models in vivo and in 
vitro [110] [111]. VEGF-A is a potent inducer of angiogenesis, being a survival factor that 
prevents the apoptosis of endothelial cells [97]. Importantly, in lung VEGF-A is a central growth 
factor regulating physiological and pathological lung formation [13]. Indeed, lung is one of the 
organs with the highest expression of VEGF in animal systems [20]. Flk-1 is the main mediator of 
VEGF-A effect. The activation of Flk1 stimulates a number of signal transduction pathways 
responsible for mitogenesis, migration, and survival of endothelial cells [97]. Our results showed 
that at pseudoglandular stage (E15.5) the activation of this crucial pro-angiogenic pathway in 
knockout animals. By contrast, at fetal saccular stage (E18.5), the opposite trend was observed 
with a down regulation of this pathway. At post-natal saccular stage (P0) the VEGF-A/Flk-1 
pathway was newly up regulated.  
Another important signalling pathway in vascular development is the Tie2/Ang system. 
While Ang-1 triggers Tie2 phosphorylation, stimulating angiogenesis, Ang-2 binds but does not 
activate Tie2, being a competitive inhibitor of Ang-1 [112]. At pseudoglandular stage a strong 
increase of Ang-2 was found. The opposite trend was observed at fetal saccular stage (E18.5), 
with the down regulation of this factor. Again, at post-natal saccular stage (P0) this angiopoietin 
was up regulated. It’s known that the activity of Ang-2 is normally anti-angiogenic.Thus, the up 
regulation found in Ang-2 would not be expected, either at pseudoglandular, as well at post-natal 
saccular stage. However, the effect of Ang2 on angiogenesis depends on the presence of VEGF: 
in the absence of VEGF, Ang2 induces vascular regression, but when VEGF is present, Ang-2 
induces angiogenesis, promoting vessel sprouting by blocking a constitutive Ang-1 signal [112]. 
The positive or negative Ang2 action is consequently dependent of VEGF-A signal. Therefore, the 
higher levels of Ang-2 could have a stimulatory angiogenic effect in macrophage-deficient mice 
lungs due to VEGF-A increase. Regarding Hif1-a, this factor belongs to hypoxia-inducible factor 
(HIF) family, which comprises three different transcription factors HIF-1, HIF-2 and HIF-3 [113]. 
HIF-1is a heterodimeric protein composed of two subunits, an oxygen-inducible subunit, HIF-1a, 
and a constitutively expressed one, HIF-1β [114] [115]. In absence of oxygen, HIF-1a directly 
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activates the transcription of the vascular endothelial growth factor (VEGF) gene and the one of its 
receptor, vascular endothelial growth factor receptor 1 (VEGFR-1) [116].  In all studied stages no 
remarkable differences were found, suggesting that the regulation of oxygen levels remains 
unaltered. As VEGF family, Fgf-2 is a potent angiogenesis inducer in vivo and in vitro, increasing 
the formation of new blood vessels [117]. In addition to a direct effect on endothelial cells, Fgf-2 
has stimulatory effect in VEGFA. Combined stimulation of Fgf2 and VEGFA angiogenic molecules 
has been associated with synergistic effects on neovascular formation in experimental conditions 
both in vivo and in vitro, increasing intercellular communication, which leads to mural cell 
recruitment and formation of mature vessels [118]. At pseudoglandular stage significant increase 
in Fgf2 was found. At this stage a up regulation of VEGF-A, Flk-1, Ang-2 and Fgf2, suggest that 
macrophage ablation leads to a stimulation of angiogenic activity, perhaps due to some 
compensation mechanisms trying to reverse the delay in lung development, demonstrated by an 
increase in mesenchymal tissue by stereological analysis. The opposite trend was demonstrated 
at fetal saccular stage (E18.5) with a down regulation of VEGF-A/Flk-1 pathway. In opposition of 
the results showed at E15.5 stage, these results suggest that macrophage ablation regulates 
negatively the angiogenic activity. The reverse of this phenotype was found at post-natal saccular 
stage with a significant increase in the transcripts expression levels of VEGFA, Flk-1, Ang-1 and 
Ang-2 demonstrating the stimulation of angiogenic activity. At pseudoglandular stage regarding 
vessel density, the results showed a minor increase of the vessel number in the knockout 
animals compared with control, which is consistent with a stimulatory effect of the up regulation 
of mentioned pro angiogenic factors. At fetal saccular stage the vessel density was slight 
decreased in macrophage-deficient mice and again consistent with the down regulation of pro 
angiogenic factors and therefore with reserve of angiogenic activity. Likely, at this stage the effort 
to try reverse the morphological impairment showed was not enough. Possible because the 
vascular density begins to be affected, still without significance, and the angiogenic activity is 
down regulated. At least, at post-natal saccular stage (P0) the angiogenic activity was increase by 
the up regulation of pro angiogenic factors. However, the poor vascular constitution showed at 
this stage become the previous results unexpected. One possible explanation could be the 
continue impairment in lung vasculature from fetal to post-natal saccular stage, which leads the 
system to try reverse this delay increasing the pro-angiogenic activity. Moreover, this tendency is 
already observed in adult lung pathologic contexts. For example, lungs from patients with severe 
forms of pulmonary hypertension a strong VEGF expression in the angioproliferative plexiform 
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lesions was found [119] [120] [121]. In mice, VEGF gene and protein expression is upregulated 
in the lung tissue after disease induction by hypoxic exposition [122].  In rat lung, mRNA levels 
for both VEGF and Flk-1 were increased using hypoxia-induced pulmonary hypertension (PH) 
[123]. The PH is characterized by an increase thickness of media and adventitia of pulmonary 
arterial walls [98]. Regarding the findings of this work demonstrating the impairment in 
vasculature and in angiogenic factors expression profile in macrophage deficient mice, the artery 
structure assessment constitutes a logic parameter to evaluate. However, no alterations in artery 
thickness were found in knockout compared with wild type mice, in any of the developmental 
stages evaluated. Therefore, these evidences indicate no influence of tissue macrophages in 
arterial walls constitution, a classical feature of PH.  
The angiogenic balance is also important in epithelial morphogenesis.  For instance, the 
main VEGF-Flk1 pathway role is on vascular system, but also it is also involved in the regulation 
of pulmonary epithelial morphogenesis, namely during alveorization, once type II pneumocytes 
and bronchiolar epithelial cells produce VEGF and express their receptors [13, 124]. It was 
demonstrated that exogenous addiction of VEGF in human fetal lung induces airway epithelial cell 
proliferation. Moreover, overexpression of VEGFA in peripheral epithelial cells leads to lung 
dysmorphogenesis [125] [126]. On the other hand, disruption of VEGFA signaling results in a 
delay of airspace maturation [124], retardation of alveolarization as well as a reduction on 
capillary number [127], being the capillary network essential for alveolar formation [96]. All 
described facts, can support the strong disruption found in morphology at post-natal stage, since 
the coordinated construction of airway epithelial and endothelial lung cell compartments requires 
a VEGF gradient, which is disrupted at this stage [20].  
Together, these results suggest that macrophage ablation is critical to lung development 
impairing airway epithelial and vascular compartments. Moreover, the close interaction between 
these two systems to the normal lung formation could explain the results of both, vascular and 
epithelial parts.  
To date, the understanding of lung macrophage function have been focused on 
pathological contexts namely in inflammation over showing their contribution during lung 
development. This study identifies tissue macrophages as critical players during lung 
development.The present work characterizes, for the first time, the effect of macrophage ablation 
on mice lung development. At least, at three different stages macrophage-deficient mice showed 
impairment of lung development in both compartments: airways and vasculature. These findings 
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open a wide perspective for future new targets to be evaluated during lung development. The 
improvement on the understanding of the role of macrophages in lung development regulation 
has potential clinical relevance, since macrophage modulation could be a target to promote lung 
development, mainly in pathological contexts, such as congenital pulmonary diseases. 
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5. FUTURE PERSPECTIVES 
 
Our previous results showed a strong delay during lung development in macrophage-
deficient mice. Macrophages contribute to development through apoptosis, phagocytic and 
removal of cellular debris and as strong effector cells producing a variety of trophic factors, which 
stimulate growth and control cellular differentiation. Therefore, the effect of macrophage ablation 
in proliferation, differentiation and cell death it’s a key target to be evaluated. 
As future perspective, also the extensive characterization of macrophage population 
during fetal lung development should be performed, quantitatively and qualitatively. Because, 
although the number and macrophage profile during post-natal development has been described 
by other groups, the number of macrophages during fetal development and also the precise 
known about how the macrophages subtypes interfere with its development remains unknown.  
In lung, during branching morphogenesis, macrophages are located abundant and 
densely located within branch points. And it is known that many of the intercellular signaling 
networks controlling the morphogenesis of branched tubular organs are conserved in the 
respiratory system. Therefore, an interesting approach could be the use a co-culture of lung 
explants with M1 and M2 polarized macrophages and the evaluation of branching process. 
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